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Abstract
Particle deposition in the pulmonary region of the lung has gained increasing interest in the past
years. Of particular interest are nano-sized particles, because they have the potential of crossing
the blood-gas barrier and into the capillaries. Many factors contribute to how and where
particles deposit, such as lung morphology, breathing conditions, fluid flow characteristics, and
alveolar wall movement. These many factors make simulating particle deposition in the alveoli
difficult. The experimental in vivo studies have commonly used micron sized particles and there
is a lack of data for smaller sized particles. Due to these many factors, deposition in the
pulmonary region is not well understood. Furthermore, little attention has been paid to the
emphysematous lungs, which have characteristics quite different than the healthy lung.
In this work, healthy and emphysematous replica acinus models were created from human lung
casts using a 3D reconstruction software package. The models were used for simulating the
particle deposition due to diffusion using Fine Particle Model (FPM). The FPM program was
validated against an analytical solution using a straight tube, before moving on to predict the
deposition in the alveolar models. Two particle sizes, 1 and 3 nm, were used to understand and
compare pure diffusion in the lung using concentration contours. Results showed the particle
deposition rate (particles/s) to be higher in the emphysemic. However, deposition rate per area
(particles/m2s) was found to be higher in the healthy model. The deposition efficiency (% of
particles that deposit) of the healthy model was greater than the emphysemic model, consistent
with literature. Results were found to be lower than experimental in vivo measurements and
whole lung model of local alveolar deposition (particles deposited in alveoli/particles entering
alveoli) in comparison to our results in the pulmonary region, showing the importance of
including axial diffusion effects. More work must be done experimentally and numerically
before an understanding of deposition of particles of this size can be determined.
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1 Chapter 1 Introduction and Background Information
1.1 Background
1.1.1 Basic Anatomy
The human lungs begin at the trachea and bifurcate into the left and right lungs. The human lung
is comprised of five lobes, the left lung is divided into two lobes and the right lung is divided
into three lobes. Each lobe is comprised of three sections: at the beginning of each branch is a
bronchi, which transitions to become a bronchiole, and each bronchiole is terminated with an
acinus (Figure 1.1(A)).

(A)

(B)

Bronchi

Bronchiole

Acinus
Figure 1.1: (A) The breakdown of the three sections of a lobe are shown. (B) A close up view of the
acinus region helps depict the spherical shape and capillaries surrounding the lung. (Netter 1979)

An acinus typically begins around the 17th generation and is defined as the region that starts
when the first alveolus occurs and ends at the lung’s termination (Figure 1.1(B)). Alveoli are
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surrounded by capillaries and are the location at which all gas exchange takes place between the
blood and oxygen rich air.

1.1.2 Emphysema
According to the National Health Interview
Survey, the prevalence of emphysema is 18 out
of every 1000 persons in the United States
(Adams et al. 2008), however, the Burden of
Obstructive Lung Disease states the prevalence
worldwide is nearly 10.1% (Buist et al. 2007).
In general terms, emphysema is the loss of
elasticity of the lung due to destruction of the
(A)

lung walls, which causes a permanent
enlargement in the acinus region (Figure 1.2).
Emphysema causes difficulty in breathing

(B)

Figure 1.2: Comparison between a (A) healthy and (B)
emphysemic alveolar sac. (http://www.healthres.com/EX/08-01-06/emphysema.jpg )

since the overall surface area for gas exchange
is minimized. It is typically caused by smoking, which causes varying degrees when toxic
particles are inhaled continuously. Currently there is no cure for emphysema, making the
destructive nature of the disease irreversible.

1.2 Particles
1.2.1 Good vs. Bad Particles
Experimental data has shown particles are capable of depositing in the alveolar region and
crossing the blood-gas barrier (Nemmar et al. 2002). Once particles cross this barrier, they have
the potential to deposit anywhere by means of the network of blood vessels throughout the body.
If these particles are toxic, cigarette smoke particles for example, they could cause adverse
effects in the lungs and other regions of the body.
If the particles are therapeutic, a better understanding of the deposition can be helpful in
eliminating invasive medicine, for example injections. A better understanding of deposition can
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also lead to a more accurate understanding of the dose, and how much is necessary for treatment
by inhalers.

1.2.2 Mechanisms of Particle Deposition
The understanding of where particle deposition occurs on the walls of the lungs and how much
can help provide an explanation into the causes of diseases such as emphysema. There are three
main mechanisms in which particles can deposit: diffusion, sedimentation, and impaction.
Typically, larger particles are deposited due to impaction and sedimentation, where as smaller
particles deposit due to diffusion.
Diffusion occurs when a particle travels from a high concentration to a lower concentration due
to a concentration gradient (Figure 1.3). Deposition due to diffusion is based upon particle size,
the smaller the particle then the higher the diffusion coefficient is for the particle. The diffusion
coefficient can be used as a comparison to describe the ease in which a particle can diffuse; a
smaller particle can diffuse a farther distance than a larger particle in the same amount of time.
The lung geometry and breathing conditions also play a role in whether or not a particle will
deposit by diffusion. For example, if a person holds their breath between inhalation and
exhalation, the particle’s residence time, or the time allowed for the particle to reach the wall, is
increased, increasing deposition by diffusion. On the other hand, if the volume of the alveolar
sac is enlarged, as in the case of emphysema, the distance the particle must travel to reach the
wall is increased, decreasing the deposition by diffusion. All parameters must be considered as a
whole to determine the effect of disease on particle deposition by diffusion.

Figure 1.3: Example of how a particle deposits due to diffusion.
(Snyder 2005)
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Sedimentation is the gravitational forces inflicted upon the particle causing it to deviate from the
path of the fluid and deposit (Figure 1.4). As for the case of deposition by diffusion, residence
time and alveolar geometer play an important role in determining the amount of deposition by
sedimentation. However, unlike diffusion, orientation of the alveolar sac will play a role in
sedimentation, since the particle’s nature will be to move in the direction of gravity by
sedimentation, whereas with diffusion the particle will move radially out from the source of the
concentration, regardless of orientation.

Figure 1.4: Example of how a particle deposits due to
sedimentation. (Snyder 2005)

Last, deposition due to impaction happens when a particle’s inertia is too high to follow the
fluid’s path around sharp contours (Figure 1.5). The momentum causes the particle to maintain
the path in which it was traveling, rather than turn the corner with the flow. The particle’s
momentum creates a collision into the wall and the particle deposits. Impaction plays a
negligible role on deposition in the alveolar sac, in comparison to diffusion and sedimentation,
because the particle’s velocity, and thus its inertia, is extremely small.
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Figure 1.5: Example of how a particle deposits due
to impaction. (Snyder 2005)

It is clear that geometry plays an important role in particle deposition; therefore it is critical that
realistic lung morphologies are used when determining particle deposition. This is particularly
important when investigating diseased lungs, since the geometry is significantly altered.
Understanding all of these mechanisms combined, and their effects on particle deposition as the
lung is changed with disease, is a key factor in improving inhaled drug delivery, which could
help treat and cure diseases like emphysema, and eliminate invasive drug delivery procedures.
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2 Chapter 2 Literature Review
Many researchers have taken interest in trying to understand the mystery which takes place
during inhalation and exhalation inside of the lungs. It has been shown routinely that convection
alone cannot be the cause for transport to the most distal walls of the lung, where gas exchange
occurs. It is generally agreed upon that convection is responsible for airflow in the conducting
airways, but convective motion decreases and gives way to diffusive motion as the airways
multiply and flow rate diminishes (Paiva 1972, Scherer et al. 1972). In the alveoli, diffusion
dominates, and at the alveolar walls, diffusion is the main mechanism for exchange of oxygen
and carbon dioxide. Unlike for gas, the extent to which aerosol particles travel by diffusion
down the airways or in the pulmonary region is not well understood. In our previous work, we
showed that in the alveolar region, diffusive motion likely dominates for smaller particles
(Harding and Robinson 2010, Berg et al. 2010). However, those studies focused on fluid flow
and did not directly calculate particle deposition. To our knowledge, models of diffusive particle
deposition in replica alveolar airways have not been presented in the literature.
For the purposes of our research, we review journal articles that used engineering models to
analyze fluid flow in the distal regions of the lung, or acinar region. Particular attention was
given to models which contained self terminating airways, in which details on alveolar shape and
dimension were given. In addition, we review articles characterizing deposition due to diffusion
and sedimentation in generalized geometries with simplified analytical formulas, and whole lung
models that utilize these simplified deposition equations. Pulmonary deposition measurements
in vivo are summarized for healthy subjects. Finally, the limited studies that have been done for
particle deposition in emphysema, in vivo measurements and lung modeling, are reviewed.
Table 2.1 is comprised of some of the literature and the details which will be reviewed
throughout this chapter.
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Table 2.1: Summary of whole lung and alveolar models reviewed, including the model characteristics and deposition mechanism addressed in each
study (N/A = Not applicable, D/MD = alveolar depth to mouth diameter ratio, X = covered in the study)

Whole Lung Models

Numerical
Alveolar
Models

Experimental

Alveolar
Radius
(µm)

Duct
Diameter
(µm)

Article

Alveolar
Shape

NCRP
(NCRP
1997)

Straight
Tube

Based on Haefelibleuer and
Weibel (1988)

Trumpet
(Yu, C. P.
and Diu, C.
K. 1983)

Straight
Tube

MPPD
(Anjilvel
and
Asgharian
1995)

D/MD

Diffusion

Sedimentation

N/A

N/A

X

X

Based on Weibel (1964)

N/A

N/A

X

X

Straight
Tube

Based on Haefelibleuer and
Weibel (1988)

N/A

N/A

X

X

Sturm and
Hofmann
(2004)

Round - Two
dimensional

Healthy based on
Haefelibleuer and Weibel
(1988)

N/A

N/A

X

X

Tsuda et al.
(1995)

Round torus on tube

Darquenne
(2001)

Round - Two
dimensional

Haber et al.
(2003)

Round Hemisphere

Sznitman et
al. (2007a)

Round single bulb
on tube

217

230

X

0.9

Kumar et al.
(2009)

Truncated
octahedron

N/A

280

X

N/A

Sznitman et
al. (2009)

14-Hedron

Based on Haefelibleuer and
Weibel (1988)

X

Harding and
Robinson
(2010)

Round

Derived from Weibel (1964)
Haefelibleuer and Weibel
(1988)

X

Karl et al.
(2004)

Square
channel

N/A

N/A

Round

122 - 140

N/A

X

Replica in
vivo

N/A

N/A

X

Oakes et al.
(2010)
Berg et al.
(2010)

200

250

Expanding

X

Based on Haefelibleuer and
Weibel (1988)
X

Axisymmetric

Emphysema

X

X

0.50 - 0.87

N/A

N/A

X

X

0.5

X

X
1.19
0.17 - 1.00

X
X

0.4 - 0.66
0.98 – 1.14
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2.1 Progression of Lung Models for Alveolar Flow
In the past, a number of various models have been used in numerical and experimental studies,
however, due to a lack of knowledge it is difficult to understand or create an argument in which
one model is superior to the next. Some of the first studies made use of axisymmetry to create
simplistic models for comparison, whereas of lately the models have begun to move closer to
what many may consider actual geometries. To this point, no one has obtained results
numerically for actual in vivo geometries, which is one of the aims in this work.
In 1994, Tsuda et al. were one of the first groups to perform a numerical Computational Fluid
Dynamics (CFD) study for a model representing the alveolar
region with moving walls. In the following year, 1995,
Tsuda et al. used a similar model best described as a straight
tube combined with a larger torus representing an
axisymmetric alveolus. The model wall expands and
contracts rhythmically and is shown in Figure 2.1. The
labels QA and QD are the alveolar and ductal flow rates,
respectively. The radii
Figure 2.1: Axisymmetric model with
moving walls used in CFD
simulations and experiments. (Tsuda
et al. 1994a, Tsuda et al. 1994b,
Tsuda et al. 1995, Tsuda et al. 1996)

of the duct and alveolus
are depicted as RD and
RA. Last, γ is explained
to be the opening half

angle. Two cases were tested, where one varied the ratio of
the alveolar to ductal flow rates (QA/QD) while keeping the
alveolar shape constant. The other case analyzed the
importance of variance in the opening half angle. The study
was shown to use a ductal radius of 250 µm and an alveolar
radius of 200 µm, which can be used to calculate alveolar
depth to alveoli mouth diameter (D/MD) ratios of 0.5 to
0.866.

Figure 2.2: Two dimensional, multigeneration alveolar model used to
solve for particle transport and
deposition with dimensions of model
parameters (Darquenne 2001)
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Later, a CFD simulation study using FIDAP was completed to better understand particle
transport and deposition in a multi-generation two-dimensional alveolated model (Darquenne
2001). Alveolar dimensions were based upon values published by Haefeli-Bleuer and Weibel
(1988). Due to a lack in computational power, a central unit (shown in Figure 2.2) was solved in
order to achieve inlet boundary conditions for each of the eight peripheral units, which were
similar in feature. Drag and gravitational forces were applied to 2 µm diameter particles using a
post-processor. Particle deposition was found to accumulate at the bifurifications of the model,
which showed good agreement to experimental studies performed on lab rats (Brody and Roe
1983).
A rhythmically expanding self similar alveolus (Figure 2.3) was solved analytically for fluid and
particle flow, along with particle deposition (Haber et al. 2003). In this study, diffusion was
neglected and only effects of sedimentation were included. Particle sizes that were studied
ranged from 0.5 to 2.5 µm in diameter while exploring
the effects of the model’s orientation on sites of
deposition.
In 2004, Karl et al. collaborated to publish their
findings in an experimental study using Particle Image
Velocimetry (PIV). The model used was an
axisymmetric straight tube representing a duct with a
Figure 2.3: Self similar hemisphere model
used to simulate effects of orientation on
deposition (Haber et al. 2003)

series of outer channels to characterize the alveoli
(Figure 2.4). Six different models were studied
containing various dimensions for the channel width

and orifice diameter while the duct diameter was kept constant. Based upon the given
dimensions, D/MD ratios ranged from 0.17 to 1.0, where the alveolar mouth diameter was
assumed to be represented by the channel width and the alveolar depth was considered to be half
the difference between the duct and orifice diameters.
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Figure 2.4: Axisymmetric model used to analyzed D/MD
ratio effects of fluid characteristics (Karl et al. 2004)

Sznitman et al. (2007a) was the first to show numerical
results in a three dimensional non-axisymmetric model
containing a single expanding alveolus (Figure 2.5). The
duct diameter, Dd, length of the duct, ld, and alveolus
radius, rA, were modified to generate models for the 8
distal generations of the lungs where dimensions were
based upon Weibel (1965). The dimensions of Sznitman’s
eighth generation, or Weibel’s 23rd, were 230 µm for a
duct diameter and 217 µm for an alveolus radius. Using
the given dimensions resulted in a D/MD ratio of 0.9.
Results stated the critical QA/QD ratio of 5.6%, to govern
the difference between recirculatory and radial flow.

Figure 2.5: Three-dimensional nonaxisymmetric model with expanding
alveolus used for simulating fluid flow in
various acinar generations of the lung
(Sznitman et al. 2007a)

2.2 Three Dimensional (3-D) Terminating Models for Alveolar Flow
Kumar et al. (2009) published their work of numerical simulations on models created by the
construction of multiple truncated octahedrons (3 hexahedral faces and 5 square faces) for
alveoli. Three cases were analyzed to depict various regions of the lower lung, however only
two of the cases were of interest. The first case of interest looked at the 2-3 generations
proximal to 23rd generation (Figure 2.6(A)). Of most interest, the last case contained a self
terminating alveolar sac (Figure 2.6(B)), which is the very similar to the models used by Oakes
et al. (2010) and my published work (Harding and Robinson 2010). Unfortunately, due to the
complexity of the building blocks of this model, dimensions of an individual alveolus are
unknown. Kumar et al. (2009) does publish the overall length to be 1045 µm and an alveolar
duct diameter of 280 µm.
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(A)

(B)

Figure 2.6: Non axisymmetric alveolar models created using
truncated octahedrons. (A) Terminal Bronchiole (B) Terminating
alveolar sac (Haribalan Kumar et al. 2009)

Using a similar alveolar building block as Kumar et al.
(2009), Sznitman et al. (2009) used truncated octahedrons
(8 hexagonal and 6 square faces), or 14-hedra, to build a
3D space filling tree. A CFD analysis was performed on
the expanding model to simulate fluid and particle flow.
The results showed recirculation to be present in
generations labeled 3-5, and reversible flow in terminal
generations (6-8) where the flow rate ratio was greater
than 0.02. Particle flow was analyzed for particle
diameters of 1 and 3 µm, where results showed the 3 µm
Figure 2.7: 3D space filling acinar tree
created using truncated octahedrons to
solve for flow and particle deposition.
(Sznitman et al. 2009)

to be largely affected by gravitational settling and the 1
µm particles to have longer residence times and be driven
primarily by convection. Additionally, the authors

looked at the effects of model orientation on particle deposition using 1 and 3 µm particles in the
model shown in Figure 2.5, which had dimensions that correlated to the 5th generation (Weibel’s
20th). The results for this model were very similar to that of the acinar tree.
Recently work has been published on flow fields in a compliant acinus replica model using PIV
techniques (Berg et al. 2010). The model used in this study was based upon a lung cast obtained
from a human cadaver and had been reconstructed using medical illustration techniques (Figure
2.8). This was the first study which analyzed in vivo replica geometry. Results of this study
found reversible fluid flow fields throughout the model under all conditions analyzed. A Péclet
11

number analysis showed the movement of 0.01 and 0.1 µm particles to be dominated by
diffusion in all locations other than the inlet.

Figure 2.8: 3D human acinus replica model
obtained from medical illustrations of a
human lung cast. (Berg et al. 2010)

Figure 2.9: 3D expanding self terminating alveolar
sac created using Weibel (1964) geometry. (Harding
and Robinson 2010)

Last, my work has been published which examined the fluid flow in an expanding self
terminating 3D alveolar sac using CFD (Harding and Robinson 2010). Different from Kumar et
al. (2009) and Sznitman et al. (2007b, 2009), the model uses spherical caps to represent alveoli
(Figure 2.9). The dimensions for creating the model were based upon Weibel (1964) geometry,
possessing a duct diameter of 0.23 mm and alveoli radii of 0.091 mm along the duct with D/MD
ratios of 1.09. Results for the fluid flow were found similar to Berg et al. (2010), reversible flow
in all regions of the model. A Péclet number analysis showed that 0.01 and 0.1 µm particle
motion would be dominated by diffusion in all regions other than the model’s inlet.

2.3 Simple Diffusion and Whole Lung Models
Whole lung dosimetry models utilize many simplifying assumptions, including straight tubes,
average velocities, uniform expansions, no axial diffusion, and mixing of tidal and residual air:
International Council of Radiation Protection - ICRP (Bates et al. 1966), National Council of
Radiation Protection - NCRP (NCRP 1997), Trumpet (Yu and Diu 1983), and Multiple Particle
Path Dosimetry - MPPD (Anjilvel and Asgharian 1995). Error gets introduced due to the straight
tube assumptions in the alveolar region. The entire alveolar region is modeled as a single open
straight tube. Figure 2.10 shows the total (Tot.), tracheobronchial (TB), and pulmonary (Pulm.)
12

deposition fractions versus particle size for a breathing frequency of 15 breaths per minute and a
tidal volume of 500 ml. Other input parameters necessary for generating this data are included in
Table 2.2.

Deposition Fraction

Whole Lung Model Deposition
15 Breaths/Min
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.001

0.01

0.1

Trumpet Tot.

1

Particle Diameter (µm)
Trumpet TB

MPPD Tot.

10

Trumpet Pulm.

MPPD TB

MPPD Pulm.

Figure 2.10: Total (Tot.), tracheobronchial (TB), and pulmonary (Pulm.) deposition fractions vs. particle size
for MPPD and Trumpet whole lung models.

Table 2.2: Input Parameters for Deposition Models

FRC (mL)

3200

TV (mL)
Breathing Frequency
(breaths/min)
Period (sec)

500

% Inhale (sec)

39% (1.56)

% Pause (sec)

4.9% (0.20)

% Exhale (sec)

56.1% (2.24)

15
4
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For decades, straight tubes have been commonly used to represent airways and model the flow in
these airways. Previous work has provided analytical formulas for calculating deposition
efficiencies due to diffusion for flow in tubes. Ingham (1975, 1984, 1991) has developed
diffusion efficiency equations for inlet flow conditions such as uniform, slug, and parabolic
profiles, assuming no axial diffusion. The equations generated from Ingham are used in the
whole lung models, MPPD and Trumpet, previously discussed. Because axial diffusion was not
included in these deposition efficiency formulas, tracheobronchial deposition of nanosized
particles will be overestimated and the transport of these particles to the alveolar region will be
underestimated. In 1994, Chen published work that derived an analytical solution for diffusion
in a self terminating, or single closed end tube, with axial diffusion. These formulations have not
been incorporated into the whole lung deposition models.
Robinson, Snyder, and Oldham (2007) used the analytical formulas from Ingham (1975, 1991) to
validate solutions of diffusion using flow in a straight tube generated by Fine Particle Model
(FPM). Unfortunately no work has been done to validate FPM’s solutions for diffusion in a self
terminating model, similar to the alveolar region of the lung.

2.4 Measurements of Pulmonary Deposition for Healthy Humans In vivo
There have been a select number of studies that have looked at and reported particle deposition
efficiency in the alveolar region of the lungs. Table 2.3 summarizes some of the studies, which
are described in more detail below.
Chan and Lippmann (1980) collected deposition data from 26 healthy, non-smoking subjects.
Tests were performed, which had the subjects inhale a tidal volume of 1000 ml at a breathing
frequency of 14 breaths per minute, using 0.2 – 0.7 µm particles. Breathing was controlled
through audible signals, with pauses discouraged. Exact data was not reported for deposition
with respect to particle size, so creating a plot was not achievable. However, the results from
Figure 7 in their report show the results for pulmonary deposition are in good agreement with the
ICRP model (ICRP 1994). The quality of this figure was not good, so it was not included.
Paiva et al. (1977) used a group of 48 smoker and 2 non-smoker males to analyze deposition of 5
+/- 0.7 µm particles. Subjects were randomly assigned tidal volumes ranging between 0.11 and
0.8 liters which was controlled and monitored. Only a single breath was studied, which required
14

a pause of 3 seconds between inhale and exhale. Alveolar deposition was estimated based upon
nomogram predictions, with no exact results reported.
Emmett et al. (1982) performed experiments on a group of 12, consisting of 10 non-smokers, 1
pipe smoker and 1 light smoker. Monodisperse polystyrene particles ranging in size from 3.5 to
10 µm, which had densities between 1030 and 1060 kg/m3, were created by air driven spinning
and coating with Tc. The subjects took 10 breaths per minute with a tidal volume of 1 L. The
alveolar deposition results are shown in Figure 2.11.
In an older experiment, the deposition in 34 subjects, 33 males and 1 female, was analyzed
(Lippmann and Albert 1969). Monodisperse, 1.3 to 7.9 µm diameter, insoluble iron oxide
spheres tagged with Au or Tc were produced with spinning disc generators. The subjects were
prompted by an audible signal to take 14 breaths per minute, whose alveolar deposition results
are shown in Figure 2.12.
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Table 2.3: Summary of experimental studies reporting pulmonary deposition vs. particle size. (N/A = Not applicable, NR = Not reported)

Study
Author
Chan and
Lippmann
(1980)
Emmett et al.
(1982)
Lippmann and
Albert (1969)
Pavia et al.
(1977)
Stahlhofen et al.
(1980)
Stahlhofen et al.
(1981)
Kim and Jaques
(2000)

Title
Experimental measurements
and empirical modeling of the
regional deposition of inhaled
particles in humans
Measurements of the total and
regional deposition of inhaled
particles in the human
respiratory tract
The Effect of Particle Size on
the Regional Deposition of
Inhaled Aerosols in the Human
Respiratory Tract
Effect of Lung Function and
Mode of Inhalation on
Penetration of Aerosol into the
Human Lung
Experimental Determination of
Regional Deposition of Aerosol
Particles in the Human
Respiratory Tract
Biological variability of
regional deposition of aerosol
particles in the human
respiratory tract
Respiratory dose of inhaled
ultrafine particles in healthy
adults

Breathing
Frequency

Health

14
breaths/minute

healthy, nonsmokers

10
breaths/minute
14
breaths/minute

10 nonsmokers, 1
light smoker, 1
pipe smoker
11 nonsmokers, 4 exsmokers, 18
smokers

Subjects
Sex
Number of Subjects

Particles
Size

NR

26

0.2-7μ

M

12

3.5-10μ

33 M, 1
F

34

1.3-7.9 µ

N/A

48 smokers, 2
non-smokers

M

50

5 ± 0.7μ

NR

non-smokers

M

3

0.5-5μ

7.5
breaths/minute

healthy

7 M, 2 F

9

5 and 7µ

15
breaths/minute

healthy

half M,
half F

22

0.04 0.1µ
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Emmett et al. (1982) Alveolar Deposition vs. Particle
Diameter
y = 0.7327e0.0222x
R² = 0.3514

Deposition Fraction

1.2
1
0.8
0.6
0.4
0.2
0
0

2

4

6

8

10

12

Particle Diameter (µm)
Figure 2.11: Alveolar deposition measured in a group of twelve people, breathing at 10 breaths per minute.

Deposition Fraction

Lippmann and Albert (1969) Alveolar Deposition vs.
Particle Diameter
0.9
0.8
0.7
0.6
0.5
0.4
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Figure 2.12: Plot showing the distribution of alveolar deposition for different particle sizes in 34 persons,
breathing at 14 breaths per minute.
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Stahlhofen et al. (1980) studied 3 healthy non-smoking males using a controlled method of
delivery. One of the male subjects was tested using two different flow rates, which produced 4
collection trials. Alveolar particle deposition was measured for particle sizes ranging from 1 to
10 µm, with flow rates ranging anywhere from 250 to 750 ml/s, while the periods were either 2
or 4 seconds. All trials followed a similar trend with a maximum deposition peak at a particle
diameter 3 µm, and sloping down on either side (Figure 2.13).
Most recently, Kim and Jaques (2000) used di-2-ethylhexyl sebacate vapor on non-hygroscopic
metallic nuclei particles to test a focus group of 22, half male and half female, ranging in age
from 20 to 40 years of age. Four particle sizes, 0.04, 0.06, 0.08 and 0.1 µm were used to analyze
alveolar particle deposition. A controlled experiment was conducted which had the subjects
inhale a tidal volume of 500 ml every 4 seconds, or 15 breaths per minute. The average results
for the 11 men and 11 women are shown in Figure 2.14.
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Figure 2.13: Plot showing the trends of alveolar deposition vs. particle deposition in three subjects, for
breathing period of 2 and 4 seconds.
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Kim and Jaques (2000) Alveolar Deposition vs. Particle
Diameter
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Figure 2.14: Average alveolar deposition results in 11 men and 11 women for four particle sizes, at 15 breaths
per minute.
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Figure 2.15: Combined experimental results on logarithmic axis for alveolar deposition versus particle size
with lines of best fit showing trends.
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Alveolar Depostion vs. Particle Size
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Figure 2.16: Combined experimental results on linear axis for alveolar deposition versus particle sizes 0 to 10
µm with lines of best fit showing trends.

As can be seen in Figure 2.15 and Figure 2.16 above, alveolar deposition for similar particles is
not repeatable or understood. Additionally, more experimental research using smaller particles
could be helpful in understanding the overall trends, especially nanosized particles (< 1 µm).
Figure 2.17 compares the experimental results to pulmonary deposition predictions using the
whole lung models. It is quite apparent there is a lack of agreement in micron sized particles;
however the few data points near 0.1 µm and lower have similar trends to the whole lung
models. It is quite possible that the very low deposition efficiency predicted for the alveolar
region is not accurate. As discussed in Section 2.3, neglecting axial diffusion could introduce
errors in these predictions for nanosized particles. In vivo data is required to verify these whole
lung model predictions.
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Figure 2.17: Plot comparing whole model pulmonary deposition predictions to actual experimental
pulmonary deposition. (Refer to legend in Figure 2.15 for experimental data)

2.5 Evidence of Decreased Deposition in Emphysema
2.5.1 Emphysemic Lung Models

(A)

(B)

(C)

(D)

Sturm and Hofmann (2004) examined particle
deposition by the combination of sedimentation and
diffusion using an improved Monte Carlo computer
code (Koblinger and Hofmann 1990) in various
models of different degrees of emphysema. This was
a whole lung model, in which the tracheobronchial
region was adjusted to represent COPD (chronic
obstructive pulmonary disease) and the alveoli were
adjusted to simulate various types of emphysema
(Figure 2.18). This model is 2D in the alveolar region
and one dimensional (axial) in the TB region. Axial
diffusion was not considered directly in this model,

Figure 2.18: Various models used to
investigate effect of alveolar shape based
upon emphysema. (A) Normal, (B)
Centriacinar, (C) Paraseptal, and (D)
Panacinar (Sturm and Hofmann 2004)
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allowing for the possibility that transport of smaller particles to the alveolar region is likely
underestimated, which in turn underestimates alveolar deposition. Air mixing in the alveolar
region is modeled with constant mixing factor based on empirical data
Particle sizes ranging from 0.001 to 10 µm in diameter were analyzed in generations ranging
from the 12th to terminal. The published results showed that particles only were able to diffuse
to the openings of the alveoli and not to the walls during a four second period. Particle deposition
was shown to be higher in the healthy model compared to models representing various types of
emphysema. Alveolar deposition was very low for small particles; however it is not clear from
the article if this is due to filtering in the tracheobronchial (TB) region, since neither total nor TB
deposition was reported. However, since plots of alveolar deposition for healthy are similar to
other whole lung models, the small alveolar deposition predicted here could be due to proximal
airway filtering.
Oakes et al. (2010) presented work on an
experimental PIV study in the most distal region of

(A)

(B)

the lung and compared the flow characteristics
between a healthy and emphysemic alveolar sac. At
the time, this was one of the first attempts to look at
a non-axisymmetric expanding model
experimentally. The number of alveoli varied from
thirteen for the healthy model and seventeen for the
emphysema model (Figure 2.19). The average
D/MD ratios were computed to be 0.66 and 0.4 for
the healthy and emphysematous models,

Figure 2.19: Non-axisymmetric alveolar sac
models used to analyze differences in fluid
characteristics of (A) Healthy and (B)
Emphysematous geometries (Oakes et al.
2010)

respectively. The overall alveolar sac lengths were 0.748 mm, while the alveolar radii were
given to be 122 µm and 140 µm, again respectively. Based upon the results, deposition due to
diffusion was estimated to be greater in the healthy model in comparison to the emphysema
model.
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2.5.2 Experimental Deposition for Emphysema
Kohlhaufl et al. (1997) performed an experimental study on 29 subjects who possessed
pulmonary emphysema. A 25 ml bolus of 0.9 µm diameter particles was inserted as patients
inhaled to lung depths of 200, 400, 600, and 800 ml. The patients then exhaled until the entire
bolus was recovered or until residual volume was achieved. Results were compared to a similar
study performed on 79 healthy patients (Brand et al. 1997), which showed the bolus dispersion to
be greater in patients with emphysema. The researchers had a number of hypotheses as to the
reasoning for these results: airway blockage, unequal spread of the disease, and uneven
ventilation.

2.6 Gaps in the Literature
A replica in vivo model of the alveolar region has never been used in a CFD simulation to solve
for particle transport by pure diffusion. Using replica geometry is helpful in understanding the
effects of the particle transport mechanisms of diffusion which helps explain how tidal air is able
to travel to alveolar walls for carbon dioxide-oxygen exchange with the capillaries. Most
researchers have used idealized geometries to predict deposition calculations in these complex
geometries; therefore, it is thought that this work gives a closer prediction to the actual
deposition. In the majority of previous studies, only a single deposition mechanism was
analyzed. Haber et al. (2003) states that even though their study neglects the stochastic
Brownian force exerted on a moving particle, the influence relative to the gravity force,
especially on small particles 0.5 µm in diameter, is still in dispute (Heyder et al. 1985) and might
prove to be potentially important.
Some insight into alveolar particle deposition has been provided by experimental research in
healthy subjects, however, rarely studies have looked at deposition of nanosized particles (less
than 1 µm), as was done in this work, and never due to diffusion only. In addition, only a few
studies have looked at how the differences in healthy and emphysematous alveolar sac geometry
affect particle transport. This research helps to further shed light on these unknowns.
This research was designed to help in understanding the phenomena of how nanoparticles are
able to reach alveolar walls in the distal regions of the lung. Unfortunately, experimental results
are difficult to obtain due to the extremely small size of alveoli and the complex geometries that
23

would be required for accurate deposition. Because of this, computers are necessary for moving
research forward. The comparison provided between replica healthy and diseased models will
further contribute to how the changes in geometry affect deposition.

2.7 Scope of Research
The goal of this research was to gain a better understanding of diffusive particle transport in the
alveolar region and to evaluate the effect of diseased lung geometry on particle deposition by
diffusion. The following aims were necessary for completion of this work:
Specific Aim 1
To create healthy and emphysematous human models to be used in a Computational Fluid
Dynamics (CFD) study by means of lung casting, Scanning Electron Micrograph (SEM),
Computed Axial Tomography (CT) scanning, reconstruction, geometry cleanup, and meshing.

Specific Aim 2
To validate and perform a CFD analysis on healthy and emphysematous models to determine the
particle concentration as a function of time and position and the particle deposition due to
diffusion.
Specific Aim 3
Compare healthy and emphysematous simulation results to each other, experimental in vivo
deposition results in literature, and whole lung model solutions from literature.
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3 Chapter 3 Theory and Validation
3.1 Brownian Diffusion and Convective-Diffusion Equation
Brownian motion is the random motion of an aerosol particle in still air caused by random
variations in the relentless bombardment of gas molecules against the particle (Hinds 1999).
Diffusion is the mass transfer of particles from a higher concentration region to a lower. Fick’s
first law of diffusion states that the mass transfer by molecular diffusion is proportional to the
diffusion coefficient. If the diffusion coefficient is uniform in all directions, Fick’s law can
defined as
(3.1)
where J is the flux (particles/m2 s), D is the diffusion coefficient (m2/s), and C is the particle
concentration (particles/m3). If Fick’s first law is applied to a finite volume element, along with
the conservation of mass theorem, the convective-diffusion equation can be derived (Gebhart
1993),
′′′

where t is time and

(3.2)

is the internal mass generation and storage in the control volume. If

applied to a cylindrical domain, the equation becomes

1

∂C
∂t

1

(3.3)

If no mass generation is present and the model’s boundaries are axisymmetric, then Equation
(3.3) can be reduced to
∂C
∂t

1

(3.4)

Equation (3.4) can be solved for particle concentration in a cylinder,

, ,

. With knowledge

of this, Equation (3.1) can be used to find the total rate of particle diffusion to the wall
(particles/s) by integrating over the area,
2

(3.5)
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where L is the cylinder length, and the inlet of the model can be represented as
2

′

(3.6)

where R is the cylinder radius. The concentration gradients found in Equations (3.5) and (3.6)
can be evaluated using a second order accurate discretization that can be found in Tannehill
(1997),
3
where

4
2∆

is the concentration at the node of interest, and

(3.7)
is the direction normal to the direction

of diffusion.
Using Equations (3.5) and (3.6), the rate at which particles deposit on the wall (particles/s) and
enter the cylinder (particles/s) can be calculated, which when summed over time, T, can be used
to calculate the total number of particles depositing on the wall,
2

Particles deposited

,

(3.8)

and entering the cylinder,
Particles entered

2

′

.

(3.9)

The deposition efficiency in the straight cylinder can then be found from
Deposition Efficiency

Particles deposited
Particles entered

100%.

3.10

3.2 Analytical Solution for a Closed-End Cylinder
A normalized analytical solution has been derived for the concentration as a function of position
and time in a straight cylinder geometry possessing a constant inlet concentration and the walls
having zero concentration in Chen (1994).
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Figure 3.1: Two dimensional (2D), axisymmetric model with boundary conditions that is derived analytically
in Chen (1994).

The entire derivation can be found in the thesis of Chen, which shows the normalized solution as

, ,

́

,

2 sinh

, ,

sinh

4

cos

sin

exp

(3.11)

where the normalized relations are
;
and

;

;

;

are the eigenvalues which satisfy the equation
0,

1, … , ∞

(3.12)

The solution to this equation was used to validate the Fine Particle Model (FPM). First, the
solution was tested to determine the effect of summation number and grid spacing, as described
in the following sections. The normalized concentration was found from Equation (3.11) and the
normalized concentration gradients were found from
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3

,

4

,

,

(3.13)

2∆
at the wall, and
3

,

4

,

,

(3.14)

2∆

at the inlet, as previously discussed. Rate of particle diffusion to the wall (particles/s) was found
using
2

′

(3.15)

,

where

is the number of nodes in the η (normalized z) direction of the mesh. Rate of particle

diffusion through the inlet (particles/s) was found from
2

(3.16)

,

where

is the number of nodes in the γ (normalized r) direction of the mesh, and

is the

normalized radius value at which the calculation is taking place.

3.2.1 Analysis on the Effects of the Number of Summations on Concentration
Gradient and Flux
In order to obtain an analytical solution, a series of summations takes place in the steady and
unsteady terms. A study was performed to better understand if the number of summations has an
effect on the final solution of σ, and if so, what is the critical number of summations before the
solution converges.

3.2.1.1 Steady Summation Effects
The steady portion of the analytical equation was first analyzed by reviewing the concentration
gradients at the model wall and inlet with increasing numbers of summations (Equation (3.11)).
Figure 3.2 shows the concentration gradients near the wall over the length of the model for
increasing summations. The concentration gradient values are shown to converge as η
approaches 0.1.
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Concentration Gradient at Wall (dσ/dγ)
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Figure 3.2: Steady summation effects on the concentration gradient near the wall. (Numbers of summations
shown in parenthesis.)

A closer look at the wall concentration gradients closest to the inlet (Figure 3.3) helps to show as
the summation number increases and approaches 100, the concentration gradient values begin to

Concentration Gradient at Wall (dσ/dγ)

converge.
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Figure 3.3: A zoomed in look at the concentration gradients closest to the model inlet helps to show values are
unaffected by summation number as η increases. (Numbers of summations are shown in parenthesis.)
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Figure 3.4 shows the same region as above, however, the summation numbers have been
increased to better show the convergence of concentration gradient. The concentration gradient

Concentration Gradient at Wall (dσ/dγ)

at the wall is converged after 150 summations.
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Figure 3.4: A second zoomed in view of the concentration gradients near the model inlet, however, with
higher summation numbers. A total of 150 steady summations are shown to be fully converged. (Numbers of
summations are shown in parenthesis.)

The analysis of summation effects on the inlet concentration gradient showed some interesting
results. The results demonstrated a sinusoidal trend at the model inlet during low total
summation numbers (Figure 3.5), however, this trend was smoothed out as the number of
summations was increased (Figure 3.6). The sinusoidal trend is caused by the Bessel functions
found in Equation (3.11), which spans the radial direction. The Bessel functions do not have any
effect on the wall concentration gradient since the γ value is constant. Similar to the wall
concentration gradient, the inlet concentration gradient was shown to converge after 150
summations.
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Steady Summation Effects near Inlet
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Figure 3.5: Sinusoidal trend of inlet concentration gradient for low summation totals. The trend is shown to
be less drastic as the number of summations increases. (Numbers of summations shown in parenthesis.)

Steady Summation Effects near Inlet
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Figure 3.6: Inlet concentration gradient has fully converged after 150 steady summations. (Numbers of
summations are shown in parenthesis.)
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3.2.1.2 Unsteady Summation Effects
A similar study was performed on the unsteady portion of the equation, using a total of 150
summations to solve for the steady state term. Although the unsteady term has two summations
that take place, the number of summations for each remained the same for consistency. The
results for wall and inlet flux for each number of summations were used as a method of
determining convergence.
The summation effects on the wall flux were found to be very insignificant after a time of 0.7
seconds, with all values becoming equal regardless of summation number. Therefore the
analysis was refined to only the first 0.7 seconds, which showed after 100 summations the results
for wall flux remained constant with increasing summations (Figure 3.7).

Unsteady Summation Effects on Wall Flux
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Figure 3.7: The number of unsteady summations is shown to no longer have an effect on the wall flux after
0.7 seconds. Prior to 0.7 seconds, 100 or greater unsteady summations are needed to ensure a converged
solution near the wall. (Numbers of summations are shown in parenthesis.)

The inlet flux findings were slightly different than those found for the wall flux. After 1 second,
the inlet flux became unaffected by the number summations that were used to calculate it. It was
not until a total of 175 summations occurred before the inlet flux had converged for times prior
to 1 second (Figure 3.8).
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Based upon the results presented, a total of 150 steady summations and 175 unsteady
summations were used in all further analyses and validations of the Fine Particle Model (FPM).

Unsteady Summation Effects on Inlet Flux
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Figure 3.8: The number of unsteady summations is irrelevant after 1 second, as is shown by all points being
equal after this point in time. Unlike the wall flux, in order for a converged solution at the inlet to occur, at
least 175 unsteady summations must take place. (Numbers of summations are shown in parenthesis.)

3.2.2 Analysis on the Effects of Grid Spacing
An analysis was conducted to determine the effects of grid spacing on Chen’s analytical model.
Since the model calculates the value at each point in the grid individually, the values of
concentration are unaffected by spacing. However, it was shown that as grid spacing values get
smaller than 0.005 (200 x 200 elements), the values of concentration gradient begin to become
unstable near the model’s inlet (Figure 3.9). This in turn causes some instability in the
calculation of the inlet concentration gradient.

33

Steady Grid Effects on Inlet Gradient near Wall
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Figure 3.9: Effects of grid spacing on the calculation of concentration gradients at the inlet of the analytical
model. It can be seen that as the grid spacing drops below 0.005 that instabilities begin to occur in the region
close to the outer radial wall. A grid spacing of 0.005 was chosen with help from this information. (Grid
spacing shown in parenthesis.)

Although instability is introduced as the number of nodes increases, some benefit does exist with
the increase in nodes. As the number of nodes increases, the inlet and wall flux values converge
(Equations (3.15) and (3.16)). This can be explained by the increase in the number of points
used for calculation; outlying points have a smaller effect on the total. To eliminate the regions
of instability near the inlet, the nodes located at η=0.01 and 0.02 were used for calculating the
concentration gradient when calculated for grid spacing’s of 0.005 and below. Similarly, the
nodes located at γ=0.98 and 0.99 were used to calculate the wall concentration gradient. Using
the normalized concentrations at the nodes located near the wall and inlet to calculate the
normalized concentration gradients, a normalized flux could be calculated for each using
Equation (3.1) and summing over the respective area. Based upon Figure 3.10, it was decided
that a grid spacing of 0.005 was satisfactory for use in further analysis.
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Steady Grid Effects on Flux Calculations
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Figure 3.10: Grid spacing effects on the calculations of the steady state inlet and wall fluxes show converged
results on models having 200 or greater nodes. A grid spacing of 0.005 (200 elements) was chosen using this
information.

3.3 Application of Fine Particle Model (FPM) to a Closed-end Tube
3.3.1 FPM Theory and Equations
The Fine Particle Model (FPM) is an add-on used by the CFD program, Fluent, to calculate the
motion of particles. FPM solves an equation known as the Moment Dynamics Equation (MDE).
The MDE is defined as
,

in which

.

conv ,

ext

,

diff ,

coag

,

cond ,

nuc ,

src ,

(3.17)

is the kth moment of mode j. Equation (3.17) accounts for the external processes of

convective transport (conv), transport by external forces (ext), diffusion (diff), along with
internal processes such as coagulation (coag), condensation and evaporation (cond),
homogeneous nucleation (nuc), and general source terms (src) (Chimera 2005). In the proposed
work, only diffusion and the external process of sedimentation will be analyzed, reducing
Equation (3.17) to,
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,

The size distribution moment term,

.

ext

diff , ,

,

(3.18)

, is solved for using the “method of moments”, where

integral moments of the modes are represented as additional scalars in FLUENT,
∞

(3.19)

,

where j is the mode number and k is the moment average of the particle distribution (where 1, 2,
and 3 correspond to particle size, surface area, and mass, respectively),

is the lognormal size

distribution of particles for mode j, and mp represents the single particle mass.
The external force term, ext , , can be used to include processes like thermophoresis,
sedimentation, and electrical and magnetic forces, by substituting various forms of the size, into ext

dependent external velocity, u

ext

,

to yield
· uext,

,

,

(3.20)

,

where
∞

uext,

,

.

u

(3.21)

is the moment-averaged external velocity of the kth moment of mode j (Chimera 2005).
Sedimentation, also called gravitational settling, is caused by the effect of gravitational
acceleration on particles, in which the particle size-dependent external velocity is expressed as,
u
where

,

is the particle density of the mode j,

viscosity, and

,

,

(3.22)
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is the particle diameter,

is the gas dynamic

is the vector of gravitational acceleration (Chimera 2005, Hinds 1999).

is

the Knudsen number defined as,
2
where

is the mean free path of the gas molecules (Hinds 1999). Last,

(3.23)
, in Equation

(3.22), is the Cunningham slip correction factor that corrects for the degree to which gas
molecules “slip” over the particle’s surface. The slip correction is characterized as
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1

1.257

0.4

.

(3.24)

Diffusion is the transport of particles by random motion caused by thermal collisions with gas
molecules, the well-known “Brownian motion”. It is represented in the FPM as the diff , term in
the MDE, or Fick’s Law, whereas in Fluent’s Discrete Phase Model (DPM) the effect of
diffusion is represented as an additional, random particle velocity. The diffusion term in the FPM
is represented as
·

diff ,
where

,

,

is the gas density and the kth moment diffusivity of mode j,

(3.25)
,

is given by

∞
,

(3.26)

,

and the particle diffusion coefficient can be expressed as
(3.27)

3
where

is the Boltzmann constant (Chimera 2005, Hinds 1999). This term varies by particle

size only, and is constant for any one particle size, therefore will be denoted as

for the

remainder of the theory.
The size distribution moment term,

.

, in Equations (3.17-21, 3.25, and 3.26) can be simply

reduced to being the particle concentration, C, when a monodisperse group of particles is used, in
which only a single mode would exist (j=1) without any size distribution (k=1). Using this
simplification, Equation (3.18) becomes the governing equation,
· uext

·

(3.28)

and Equation (3.19) becomes
∞

.

(3.29)

When Equations (3.21) and (3.26) are substituted into Equation (3.28), it becomes,
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∞

·

u

,
∞

·

(3.30)

Using the right hand side of Equation (3.29) to simplify, Equation (3.30) reduces to
·

u

·

,

(3.31)

Combining the divergence terms, Equation (3.31) becomes,
·

u

(3.32)

,

Last, if the carrier gas is incompressible and Newtonian,

and

will not change with position

·

(3.33)

and a final reduction yields
,
molecular diffusion

gravitational settling

which can be used to solve for the concentration in the flow field as a function of time, due to
molecular diffusion and gravitational settling. FPM applies Equation (3.33) to find the
concentration as function of position and time. Once the concentration is known, the flux
(particles/s) can be found by extracting concentration values by using rakes and Equations (3.5)
and (3.6). If a rake is not capable of getting accurate concentrations near surfaces, as in complex
models, the particle fluxes are output for each of the boundary condition surfaces of the model.
The deposition efficiency can be determined from the ratio of the particles entering through the
inlet to the particles depositing on the wall, using Equations (3.8-10).

3.3.2 Grid Convergence Study
A grid convergence study was conducted on a straight tube having an alpha value of 1.0, which
means the radius is equal in dimension to the length of the cylinder. The same boundary
conditions were applied to the 3D cylinder as shown in Figure 3.1, however the axis has been
moved. The C0 concentration has been moved to the z=0, or η=0, plane and the z=l0, or η=1,
plane is set to C=0. The criteria used for determining a good mesh was satisfaction of the
boundary conditions near the inlet (η=0) and wall (γ=1). The solution near these particular
locations is of utmost importance because they will be used for calculating particle deposition
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and deposition efficiency. Figure 3.11 shows how each of the boundary conditions were applied
to the straight cylinder.

Figure 3.11: Boundary conditions applied to the straight cylinder in FPM.

Meshes having a uniform grid spacing of 0.1 (4,000 elements), 0.05 (32,000 elements), and
0.025 (256,000 elements) were each created using GAMBIT, and steady solutions were solved
for using FPM. The concentrations exported from the FPM solution were all normalized by the
inlet concentration, C0, and axial and radial dimensions were normalized by l0 and r0,
respectively, as shown in Section 3.2. Concentration contours were created for rakes in the axial
direction at a radial (γ) location of 0.98 (Figure 3.12 and Figure 3.13). In order to satisfy the
boundary conditions, the rakes should show a value of 1.0 at η=0 and value of 0 at η=1. None of
the uniform meshes were capable of satisfying these conditions at γ=0.98.
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Concentration Contours at γ = 0.98
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Figure 3.12: Normalized concentration contours shown for various grid spacing’s, each at γ = 0.98 and
spanning from the model inlet to the end wall.

Figure 3.13 helps to better show the concentration contours by zooming in near the region of the
inlet, since it is apparent that grid spacing has little effect on the solution after approximately
η=0.15.

Concentration Contours at γ = 0.98
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Figure 3.13: Expanded view of same concentration contours as Figure 3.12 near the model inlet to help
illustrate each individual grid spacing contour. It is shown that no grid spacing of 0.025 and higher is capable
of matching the desired boundary condition.
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An additional set of rakes was taken closer to the wall at the axial location of γ = 0.99 and
concentration contours were plotted for each of the meshes (Figure 3.14 and Figure 3.15).
Again, the results showed the uniform grid spacing’s incapable of matching the boundary
condition at η=0.

Concentration Contours at γ = 0.99
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Figure 3.14: Normalized concentration contours are shown for decreasing grid spacing’s. Each contour was
taken along the axial rake of γ = 0.99.

Once again, the contours are shown to be unaffected by grid spacing after η=0.15, Figure 3.15
helps to better show the contours near the inlet. Not shown, grid spacing was decreased to a
value of 0.01316 (1/76th) creating a mesh with 1,316,928 elements, which approached the
maximum number of elements that could be simulated due to computer restrictions, however, the
results still did not agree with the boundary conditions at a rake of γ = 0.99.
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Concentration Contours at γ = 0.99
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Figure 3.15: Zoomed in view near the inlet of the normalized concentration contours of Figure 3.14. It is
shown here that uniform grid spacing is not capable of matching the inlet boundary condition of 1.

A boundary layer was used in order to reduce the number of elements and to improve the
accuracy of the solution near the wall. Before a boundary layer could be implemented, it was
necessary for the model to be decomposed into quarters, which allowed for a Cooper mesh to be
applied. A boundary layer was applied to each end of the model, an initial cell height of 0.005
was grown 10 rows using a growth factor of 1.1958 from the outer radius towards the axis of the
model. After application, the model was re-meshed using a grid spacing of 0.025. Similar to the
uniform meshes, the boundary conditions were applied and the FPM was used to solve for a
steady solution. The concentration contours for the solution can be seen in the above Figure
3.12-Figure 3.15 as depicted by the line titled “0.025 w/ BL”, which is shown to satisfy the
boundary conditions at both γ=0.98 and γ=0.99.
In addition to concentration contours in the axial direction, concentration contours were also
produced for the radial direction. Rakes from the center of the cylinder to the outer radius were
created at η=0.01 and η=0.02 for each of the meshes, and the values of concentration were
plotted. The boundary conditions needed to satisfy consisted of σ=0 at γ=1 and

=0 at γ=0.

The uniform 0.025 mesh and 0.025 mesh with a boundary layer were each unsuccessful in
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meeting the boundary condition requirements at η=0.02, and both failed at satisfying the σ=0 at
γ=1 condition at η=0.01.
It was not until a second boundary layer was applied to the inlet in the axial direction of the
cylinder, that the boundary conditions requirements were met at η=0.01. Again, an initial cell
height of 0.005 was grown 10 rows using a growth factor of 1.1958 from the inlet of the
cylinder. Continuing to use a 0.025 mesh with a radial and axial boundary layer produced
desirable results and a final mesh of 256,000 elements and 262,441 nodes (Figure 3.20). The
results for the 0.025 spaced mesh with two boundary layers are shown in the previous and
following figures and are appropriately labeled as “0.025 w/ 2 BL”.

Concentration Contours at η = 0.02
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Figure 3.16: Radial concentration contours at a location of η = 0.02 for varying meshes.

In the following section, this grid independent solution for a closed-end cylinder is compared to
Chen analytical model for validation.
In conclusion, a grid-independent solution for diffusion in a closed-end tube was obtained in
FPM for the grid shown in Figure 3.20. The validation of this solution with Chen is discussed in
Section 3.4.
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Concentration Contours at η = 0.02
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Figure 3.17: Improved view near the model wall of Figure 3.16 helps to show that a grid spacing smaller than
0.025 is needed in order to agree with the boundary condition.

Concentration Contours at η = 0.01
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Figure 3.18: Radial concentration contours, similar to Figure 3.16, but at a location of η = 0.01, which is
closer to the model inlet in the axial direction. For a better representation of the boundary condition near the
wall, look forward to Figure 3.19.
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Concentration Contours at η = 0.01
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Figure 3.19: The importance of the second boundary layer, projected axially, in matching the boundary
condition is shown. The single boundary layer, which is projected in the radial direction, is not helpful in
improving the accuracy in the axial direction. The .025 mesh with two boundary layers was chosen for final
comparison to the Chen model.

Figure 3.20: Quarter section of straight cylinder converged mesh showing boundary layer mesh at inlet (top
of left and right squares) and wall (outer edge of left and right squares), as well as, hex-wedge on the model
inlet face (top).
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3.4 Validation of the Fine Particle Model (FPM)
The straight closed-end cylinder geometry created in Section 3.3 was used to validate the
solution of the FPM with that of Chen’s analytical model. The validation of the FPM was
performed in two separate steps, first the steady state solution was compared to the steady
portion of the analytical model. Second, the unsteady state portion was added to the analytical
model which was then compared with unsteady FPM solutions.

3.4.1 Steady State Solution
The steady state solution from the FPM grid convergence study was used to evaluate against the
steady analytical model solution. The double boundary layer mesh (Figure 3.20) was solved
iteratively using FPM until residuals were reduced to a value of 1e-10. The analytical model was
solved using a 0.005 spacing (200 x 200), which was summed a total of 150 times, as explained
in Section 3.2.1.1.
Axial rakes (along z-axis) at various radial positions were taken from each steady state solution
and the values of concentration were compared (Figure 3.21). Great agreement is shown at each
location throughout the length of the cylinder.

Steady Solution Validation (Axial Rake)
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Figure 3.21: Excellent agreement is shown between the steady solutions of Chen and FPM. A series of axial
rakes of normalized concentration values have been shown, where Chen solutions are the lines and FPM are
the points. (γ = Normalized Radial Position)
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Although good agreement is found in the central location of the cylinder, results from the grid
study have shown that the region closest to the wall can be inaccurate while the rest of the model
shows results of no concern. It is the wall region that is of the most importance because the
concentration gradient is calculated here, which is directly related to the flux at the wall. Figure
3.22 shows the normalized concentration values along two axial rakes in close proximity to the
wall of the cylinder. Close agreement is shown in each of the rakes, which were used to
calculate the concentration gradient at the wall in Figure 3.25.
Additional rakes were taken spanning from the center axis to the wall of the model at intervals
along the axial direction. Again, the values for concentration were taken at each of the nodes
along the rake and compared to the analytical solution along the same plane. Figure 3.23 shows
the results from each of these comparisons, and verification of the boundary conditions. The
rake along the inlet, η = 0, shows a constant value of 1, as desired. At the rake along η = 1, a
constant value of 0 is shown to occur, again matching the boundary conditions. Last, the slopes
(dσ/dγ) for each data set is shown to approach 0 at γ=0.
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Figure 3.22: Great agreement is also shown between Chen and FPM for axial rakes at the locations of γ = 0.98
and γ = 0.99. These two rakes are of particular importance because they will be used for the calculation of
particle flux at the wall. (γ = Normalized Radial Position)
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Steady Solution Validation (Radial)
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Figure 3.23: A comparison of radial concentration contours is shown between Chen and FPM, which are
taken at a series of axial locations along the model. The verification of the boundary conditions is easily
represented here. (η = Normalized Axial Position)

It was important to ensure that results in close proximity to the model inlet were accurate
between the analytical model and FPM. Instabilities were already shown to occur in the
analytical solution in regions close to the inlet, and an additional boundary layer was necessary
to extract the correct solutions for boundary conditions in FPM solution. Rakes for the two
planes near the inlet are shown below in Figure 3.24. The steady analytical and FPM solution
are in great agreement and show no signs of instability or inaccuracy near the wall.
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Figure 3.24: Good agreement of the concentration contours is shown near the model inlet, these contours
were used in calculating the model’s inlet flux. (η = Normalized Axial Position)
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The normalized concentration gradients at the wall and inlet were compared for the analytical
model and FPM. The concentration gradient at the wall was found as a function of the axial
location (η) and the inlet concentration gradient was found as a function of radial location (γ)
(Figure 3.25). Good correlation has been shown for each gradient, which would be expected
based upon the accuracy of the concentration contour results found in regions close to each.
Based upon the results shown, it was determined that the FPM solution is valid and accurate
under steady state conditions. The non-dimensional results shown can be applied to cases of
similar boundary conditions if the geometry is known.

Steady Solution Validation at Wall and Inlet
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Figure 3.25: An evaluation of the concentration gradients at the wall (dσ/dγ) and inlet (dσ/dη) for solutions of
Chen and FPM provides good results, as would be expected based upon the great agreement shown in Figure
3.22 and Figure 3.24.

3.4.2 Unsteady Solution
Unsteady solutions for Chen’s analytical model were used for validation of the unsteady
solutions of FPM at three different points in time: 1, 3, and 5 seconds. Chen’s model is capable
of producing solutions for discrete points in time because it does not build upon solutions from
previous times.
The unsteady FPM solution is obtained iteratively and requires time stepping in order to produce
accurate results. The boundary conditions were setup so that a constant concentration of
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particles was being introduced at the inlet for all time, as shown in Figure 3.11. Using a time
step of 0.1 seconds, the case file was solved for a total of 50 time steps. Each time step was
solved iteratively until residuals fell below 1e-9.
Concentration contours were reviewed at each of the times for solutions of each of the models,
similar to those shown in the steady comparisons. Good agreement was shown for all contours
at each of the times chosen for the wall. However, at the inlet, the concentration contours were
shown to vary between Chen and FPM (Figure 3.26 – 3.28). Ultimately, it is the concentration
gradients that are of importance since it is these which are used in calculating particle flux (rates
of particles entering and particles depositing).
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Figure 3.26: Unsteady concentration contours near the inlet at time = 1 second. (η = Normalized Axial
Position)
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Unsteady Validation at Inlet (3 second)
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Figure 3.27: Unsteady concentration contours near the inlet at time = 3 seconds. (η = Normalized Axial
Position)

Unsteady Validation at Inlet (5 second)
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Figure 3.28: Unsteady concentration contours near the inlet at time = 5 seconds. (η = Normalized Axial
Position)

The concentration gradient along the wall has been plotted versus the axial position for solutions
at 1, 3, and 5 seconds in Figure 3.29. Since the gradient rapidly approaches zero as η, only a
small portion of the axial data is represented in the figure. The lines correspond to the solution
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based upon normalized concentrations from Chen’s analytical model and the points represent the
results from FPM. The solution from FPM is shown to agree very well with that from the
analytical model at each of the chosen times.

Unsteady Solution Validation at the Wall
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Figure 3.29: The concentration gradient along the wall is shown for three different unsteady times. The plot
has been magnified in the axial direction since the gradient rapidly approaches 0 in all cases. Good
agreement is shown in each of the cases.

Similarly, the concentration gradient at the model’s inlet was plotted as a function of radial
position for the same points in time (Figure 3.30). The solutions from each of the models are
shown to have similar trends; however, the values are not in direct agreement. The disagreement
of the concentration gradients at the inlet is generated by the disagreement of concentration
contours shown in Figure 3.26 – 3.28. At each of the points in time, the percent difference was
found to be roughly 6% (4.2% at 1 second, 6.2% at 3 seconds, and 5.7% at 5 seconds) between
FPM and analytical solutions.
Although some issues were found in the unsteady solution near the model inlet, the results did
not cause concern with the accuracy of the FPM. Using the Chen model as a method of
validation, the FPM was considered valid for unsteady solutions.
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Unsteady Solution Validation at the Inlet

1

Normlaized R Direction (γ)

0.9

Time = 1.0 (Chen)
Time = 1.0 (FPM)
Time = 3.0 (Chen)
Time = 3.0 (FPM)
Time = 5.0 (Chen)
Time = 5.0 (FPM)

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0

20

40
60
80
100
120
Normalized Concentration Gradient at the Inlet(dσ/dη)

140

Figure 3.30: Concentration gradients at the inlet are shown for three unsteady points in time, a slight shift is
noticed in all cases, which attributes to roughly a 6% difference between Chen and FPM.
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4 Chapter 4 Model Creation
4.1 Cast Lungs of Human
The lungs from a healthy and emphysematous human cadaver each were cast based primarily on
a procedure described in the literature (Phalen et al. 1973). The lungs were obtained from the
RIT cadaver lab (Biosciences Dept.), each from an adult male of undisclosed health background.
Our agreement with University of Rochester does not allow detailed knowledge of the cadaver
health or any personal identifying history.

4.1.1 Healthy Human Lung Cast
Similar to the procedure explained by
Phalen (1973), the tertiary
bronchiole, located just proximal to
the posterior and lateral basal
sections of the lower lobe of the left
healthy lung, was cannulated (Figure
4.1). The bronchiole was cannulated
by using a 10 ml disposable pipette,
which was epoxied into position with
the lung. The bulb end was removed
and a piece of ¼ inch diameter
polyethylene tubing (MSC Direct
Part # 74204801) was inserted and

Figure 4.1: Illustration of medial view of left lung with detailed
labeling of lobes(Netter 1979). Red circles show the lobes that
were casted in the healthy human lung.

epoxied for structural support and to create a junction for connecting. The polyethylene tubing
provided a great seal with the 3/8 inch diameter Tygon tubing (MSC Direct Part # 79814620)
that was connected to the CO2 tank regulator.
CO2 gas was used to inflate and deflate the lungs numerous times until a desired effect had been
achieved. The cycling was dual purpose; first, since the cadaver had been fixed with
preservatives, inflation was desired in an attempt to revitalize the lung’s elastic properties, which
was slightly effective. Second, the CO2 was cycled in an attempt to remove and replace any air
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that was previously in the lungs. Some elasticity was shown to return after a number of full
inflations of CO2; it was not expected that all gas be exhaled by the lung’s elasticity alone. The
lungs typically return to FRC after inhalation, which is similar to our observations. Additional
compression to the lobes was required to completely exhaust all gases inside. Once it was
comfortable that the lungs no longer contained air from atmosphere and were filled solely with
CO2, approximately 80 ml of saline was instilled into the lobes using a systolic pump at a flow
rate of 80 ml/hr. It is important to note that an immeasurable volume of saline diffused out of the
lung’s membrane during the instillation process. The properties of saline allow it to absorb the
CO2, as well as, be capable of diffusing through the lungs when a positive pressure is applied.
By removing all of the CO2, the intention was to create a lung cast with no bubbles that
otherwise would be trapped in the casting material.
Next, the saline was displaced with the casting
material, Dow Corning 3110 RTV, which was

2.5 in

mixed with Dow Corning S Catalyst at a ratio of
20:1 (RTV to Catalyst based upon mass). This
ratio correlates to the maximum working time of
3 hours, as per Dow Corning. A series of 140 ml
syringes, which had been adapted for this
procedure, were filled with 3110 RTV mixture.
The luer lock tip of the syringe was removed to
allow the least resistance by using a ¼ inch drill.
After drilling, a piece of 3/8 inch diameter Tygon
tubing was epoxied over the syringe’s tip, the
same tubing as connected to the CO2 regulator

Figure 4.2: Digital picture of healthy human lung
cast showing the complex human airways after all
tissue has been removed. Scale in upper right
corner shows the line to be approx. 2.5 inches.

used prior. After securing the Tygon tubing to the polyethylene tubing using a zip tie, a KD
Scientific KDS210 syringe pump was used for the first hour of instillation, which was when the
force necessary to continue became too great for the pump. The total volume of 3110 RTV
inside of the lungs was determined to be approximately 10 ml, based upon the KDS210 read out.
After waiting one week to allow the material to cure, the lungs were introduced to a 4M NaOH
solution to dissolve all the surrounding lung tissue. To help speed the process, large portions of
the lung were removed that did not contain casting material. By doing so, it allowed the NaOH
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solution to work effectively on the desired portion only. The NaOH solution was removed with
any dissolved tissue and routinely replenished with fresh solution (Figure 4.3) until finally a
complex airway structure remained (Figure 4.2).

Original

2-3 days

21 days

24 days

9 days

16 days

Completed - 27 days

Figure 4.3: Series of digital pictures (labeled with timed intervals in base) starting with original
healthy human lung to the final lung cast. The white circle in Original shows the airway that
was cannulated.

4.1.2 Emphysema Human Cast
The emphysema lung was cannulated in two locations, so that two casts could be created after
decomposition of the tissue had been completed. Since the entire lung must be dissolved to
release the cast, the upper anterior and lower superior lobes (Figure 4.1) of the left lung were
cannulated to insure that at least a single piece of interest would be created. Unlike the healthy
lung, the availability of another emphysemic lung was not present, therefore extra caution was
taken to insure that a successful cast would be created.
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First bronchiole casted

Second bronchiole casted

Figure 4.4: Digital pictures showing locations of emphysemic lung that were cannulated.

The same procedure as discussed to cast the healthy human lung was used for each emphysema
lobe, however, some changes existed in the volumes of saline and 3110 RTV that were infused.
A volume of 80 ml of saline and a volume of 60 ml of 3110 RTV was pumped into each of the
lobes. The method for infusion of RTV into the lungs was improved, allowing for larger
volumes to be injected. Previously a syringe pump was used, which only allowed for a
maximum of 40 lbs of linear force to be applied. The syringe pump was desirable because of its
accuracy in volume; however the force limitations were far too great. It was assumed the
volume of the emphysema lobe be much larger than that of the human. Based upon the volume
at which saline began to diffuse through the lung membrane as an estimate to TLC, the volume
of 60 ml was chosen. A caulk gun and syringe were slightly modified to fit each other and
allowed for the additional volume of RTV to be injected. Using a standard caulk gun,
mechanical advantages of 20:1 (force exerted to force applied) or greater were easily achieved.
The casting procedure for the second lobe was performed three days after the first lobe to help
eliminate any unnatural features that may occur in the cast during the handling and the
expanding and contracting.
To allow evaporation of the fixing agent, a wait of seven days took place before introducing the
emphysema lung cast into the 4M NaOH solution for decomposition. Again, the solution was
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replaced and deteriorated tissue was removed on a regular basis. After a month of this process, a
cast for each of the lobes was exposed (Figure 4.5).

Original

7 days

14 days

Completed – 30 days

Figure 4.5: Digital pictures showing the periodic progress of emphysema human lung casts. The plastic inlet
tube diameter (circled in each image) is 0.375 inches for reference to size of the casts.

4.2 Selection by Microscope and SEM of Desired Location
4.2.1 Healthy Lung
After casting, three pieces of the healthy lung cast were removed (shown in Figure 4.6) to be
examined under a high powered microscope to help locate regions of particular interest. Regions
of interest were chosen based upon alveolar size, shape, completeness, presence of an inlet duct,
and absence of air bubbles.
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Piece 3
Piece 1
Piece 2

Figure 4.6: Pieces and their locations on the healthy human lung cast chosen for further inspection in
the SEM. Piece 1 is shown in the white circle in (A) and the two white circles in (B) are Pieces 2 and 3.
As a reference to the scale of each image, the inscribed lettering (boxed) is 0.25 inches tall.

A Scanning Electron Micrograph (SEM) was
later used to obtain photos containing a better
depth of field and further magnification.
Unfortunately, the size constraints for nano CT
scanning are that the sample must not be larger
than 1 millimeter in any single direction. While
reviewing these samples under the high powered
microscope, it was determined that a nano CT
scan of the samples would not prove to be
beneficial (Figure 4.7). Due to the size
constraints, it would only allow a few alveoli to
be scanned and reconstructed. This is mainly due

Figure 4.7: High magnification microscope picture
of healthy lung cast piece chosen with scale. The
white line on the scale is 1 mm in length.

to the fact that human alveoli are 250 um in diameter (Haefeli-Bleuer and Weibel 1988). SEM
pictures were taken for each of the three pieces as they were cut from the original cast (Figure
4.8). The quality of the healthy lung cast pieces were thought to be a good representation of the
acinus region based upon illustrations and photos from previous literature, as well as
expectations. During the casting procedure, the inside of the lung was examined and was filled
with extremely dense, sponge-like tissue making up millions of very small air sacs. Although
the morphology of this region of the lung is not well understood, it was felt that all measures
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were taken during casting in order to properly recreate it. Piece 2 was finally chosen for
continued analysis and reconstruction.
(A)

(B)

(C)

Figure 4.8: SEM photographs of each of the three pieces, (A) Piece 1, (B) Piece 2, and (C) Piece 3,
trimmed from the healthy human lung cast.

4.2.2 Emphysema Lung
Two larger pieces were removed from the emphysema lung cast for further observation (Figure
4.9) under a high powered microscope. A first examination showed the alveolar sacs to be much
larger in size, and lack of definition in comparison to the healthy cast (Figure 4.10). Although
the emphysema casts showed these features, this was expected based upon observations during
casting. The emphysema lung prior to casting showed extreme signs of tissue degradation and
very large air sacs. This is portrayed in the lung casts and helps to prove the quality of the
emphysemic casts in representing the actual diseased lung.

Piece 2
(A)

(B)

Piece 1

Figure 4.9: (A) Digital picture of the upper anterior lobe of the emphysema lung cast. (B) Zoomed in
location of where the two emphysemic lung cast pieces were removed from (white circles). The white box in
(A) illustrates the region that is zoomed in on in (B).
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Using similar criterion as for the healthy lung piece of alveolar size, shape, completeness, and
absence of air bubbles, the second emphysematous piece was chosen for reconstruction and
analysis (shown in Figure 4.10).

4.3 CT Scanning of desired location
Computed tomography (CT) or computed axial
tomography (CAT) is a medical imaging method
employing tomography created by computer
processing, whereby tomography is imaging by
sections or section, through the use of wave
energy (Hanks 2009). In the past 20 years, CT
scanning has become increasingly popular in
medicine, as well as, in nondestructive material
testing.
CT scanning was implemented in order to

Figure 4.10: Microscope picture of emphysemic
acinus showing much larger alveoli than healthy
(compared to Figure 4.7). The white line on the
scale represents a distance of 1 mm.

generate a series of two-dimensional (2D) axial digital images for each of the chosen healthy and
emphysematous lung cast pieces. From the series of images, a three dimensional (3D) digital
reconstruction can take place, which can be used in various computer software packages.

4.3.1 Vendor Selection
During earlier research, micro CT scans of a healthy 12 week old C57BL/6J female mouse lung
cast were performed at SUNY Upstate Medical University (Syracuse, NY) which was performed
by an in vivo micro CT scanner. After in depth looks at the scan slices that were created, some
doubt existed as to the quality of the resolution that would be received after digitally
reconstructing the lung model. A human alveolus is roughly 250 µm in size and SUNY
Upstate’s scan resolution is limited to a minimum of 37 µm per pixel, causing further research
into other vendors and the discovery of high resolution micro CT scanning (Table 4.1). In vivo
micro CT scanners are unable to get the same resolution due to the time required for scanning, it
is not recommended to subject the live specimens to the increased amount of radiation that is
required. Based on Table 4.1, the High Resolution micro CT scanning capabilities of Micro
Photonics (Allentown, PA) were chosen for the healthy and emphysematous human lung casts.
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The deciding factor between the vendors, Micro Photonics and Scanco Medical, was time for
delivery/completion, experience with scanning similar samples, and capabilities of future nano
CT scanning.
Table 4.1: CT vendors considered and their scanning capabilities.

Vendor

SUNY Upstate

Micro/Nano

In vivo Micro

Rates
Resolution
(microns/pixel)

$258

Image Size

3072 x 2048

Image Format

16 bit RAW
8 cm (axial) x 5.4
cm (transaxial)
5.4 cm (axial) x 8
cm (transaxial)

Scan
Dimensions

Micro Photonics Micro Photonics
High Resolution High Resolution
Micro
Nano
$400-1000
$1,200

37

3 to 8
2k x 2k 4k x 4k
8 bit Bitmap
10mm - 78mm
diameter (width)
155mm diameter
(height)

Scanco Medical
High Resolution
Micro
$350

0.4-0.7
1280 x 1280
8 bit Bitmap
1mm max.
diameter
5 mm max.
height

6
512 x 512 4096 x 4096
n/a
8 mm max.
diameter
140 mm max.
length

4.3.2 Image and Scan Results
The two selected pieces of the healthy and emphysema lung casts were sent to Micro Photonics
for micro CT scanning.
The healthy piece of roughly 6 mm in size was micro CT scanned at two resolutions. The first
scan resolution was 1.79 µm/pixel, this resulted in a total of 2,294 slices. Each slice was a 2680
x 2680 pixel 8 bit bitmap image, which had a file size of 7,016 KB. The second scan resolution,
twice the first, was 3.58 µm/pixel and created 1,241 slices. The file size was reduced to 3908
KB for each of the 2000 x 2000 pixel images.
The emphysema piece was micro CT scanned at only a single resolution of 3.35 um/pixel. The
scan of the 12 mm piece produced 3,550 images, each a 4000 x 4000 pixel 8 bit bitmap picture.
The file size for each image was 15,267 KB.
The effects of emphysema can easily be observed when comparing the cross section images of
the healthy and emphysema lung casts (Figure 4.11). Each slice is at nearly the same
micron/pixel resolution (3.58 vs. 3.35), however the emphysema slices contain twice as many
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pixels in each direction (2,000 vs. 4,000). It is very evident that individual alveolar walls break
down and the sacs merge into larger air spaces.

(A)

(B)

Figure 4.11: Examples of micro CT images slices shown in ImageJ from (A) the healthy lung cast and (B) the
emphysema lung cast. It is important to note that the scale of each picture is not identical, which
dramatically shows the adverse effects of emphysema. To help illustrate, the white line in the images is 1 mm.

4.4 Reconstruction of Slices in 3D Doctor
The 3D Doctor software package, created by Able Software Corp., is an advanced 3D modeling,
reconstruction, image processing and measurement software for MRI, CT, microscopy, scientific
and many other medical and industrial imaging applications. 3D Doctor allows the choice
between three different segmentation techniques: manual tracing, edge based segmentation,
thresholding and region growing. After all the images have been segmented, 3-D surface or
solid files can be created to be used for surgical planning, simulation, quantitative analysis, finite
element analysis (FEA) and rapid prototyping applications.

4.4.1 Interactive Segmentation
The thresholding segmentation technique was chosen based upon the research provided in Jackie
Russo’s thesis (Russo and Robinson 2007). After a region of interest was setup for the image
set, the interactive segmentation feature allowed for all slices in the series to be segmented at one
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time. The segmentation option of ‘Outline Only’ was necessary to eliminate the creation of
inaccurate internal surfaces (Figure 4.12).

(A)

(B)

Figure 4.12: 3D Doctor screenshots of two options (A) ‘All Boundary Lines’ and (B) ‘Outline only’ that can
be selected during interactive segmentation. The image shown is a slice from the emphysemic human cast.

After a small study, it was determined that thresholding values between the limits of 45 and 255
provided the most optimal results, as it included the largest majority of the cast surface without
including too much of the surrounding static. These limits were used throughout the rest of the
reconstruction procedure.

4.4.2 Simple Surface Rendering
After all images were segmented based upon thresholding, the simple surface rendering tool was
used to stack the images and create a 3-D surface. Before this process can take place, it is
required to input the pixel dimensions (length, width, thickness between slices) so that the
program knows the voxel (pixel3) dimension. This ensures the rendering stacks the images to the
same scale and accuracy. In our case the distance between slices was the same as the pixel
length and width, therefore, no changes were necessary.
In order to look at the effects of the reconstruction a 3D editing software program, VP Sculpt,
was used. VP Sculpt is a computer aided sculpting software package created by Colorado State,
which allows editing, reshaping, and repairing of the model’s surface or to individual facets.
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Some features of the program include smoothing, decimating, refining, filling holes, and
removing improper facets.

4.4.3 1.79 vs. 3.58 µm/pixel resolution scans
The 1.79 µm resolution healthy scan (Figure 4.13A) appeared to be picking up crater like pits in
the alveoli (shown in Figure 4.13C) that were not present during views of the cast under a high
powered microscope or SEM. Whereas the 3.58 µm resolution healthy scan appeared to show
the scan planes (horizontal lines across the entire scan), as shown in Figure 4.13D. However, the
major features of the alveolar shape are captured adequately in the 3.58 µm resolution healthy
scan (Figure 4.13B).

(A)

(B)

(C)

(D)

Figure 4.13: VP Sculpt screen shots of the reconstructions using the (A) 1.79 micron/pixel scan (top 500
images) and (B) 3.58 micron/pixel scan (all images) of the healthy model. (C) Zoomed in view of 1.79
micron/pixel scan to illustrate pits in the surface. (D) Zoomed in view of 3.58 micron/pixel scan showing the
horizontal scan planes.
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The disadvantage of the 1.7 µm healthy scan is that the number of images exceeds the memory
allocation in VP Sculpt so that it would be necessary to reconstruct the model in at least 5 or
more sections (Table 4.2 shows the details). The 3.5 µm scan files were chosen for the healthy
model because they could be reconstructed all together as a whole and all of the desired features
were accurately captured.
Table 4.2: Reconstructions of the healthy model performed to determine optimal scan resolution.

Scan
Included Slices
(micron/pixel)
1.7
All
1.7
Bottom 500 (1989-2488)
1.7
Bottom 1000 (1489-2488)
1.7
Middle 500 (1488-1988)
1.7
Middle 250 (1739-1988)
1.7
Middle 250_2 (1489-1738)
1.7
Top 500 (197-696)
1.7
Middle 250 (697-946)
3.5
All (29-1289)

Nodes

Triangles

8,011,235
2,262,058
9,566,269
5,615,533
2,918,434
2,697,097
1,270,474
2,640,542
3,759,282

16,062,990
4,538,955
19,941,612
11,488,549
5,950,428
5,536,585
2,539,475
5,327,977
7,516,779

Opens in VP
Sculpt?
No
Yes
No
No
Yes
Yes
Yes
Yes
Yes

Upon completion of the preliminary segmentation and simple surface rendering of the healthy
human set of slices, it was noticed that some additional noise or static was present in the images
close to the edges of the cast (shown in Figure 4.13). Additionally, the presence of small air
bubbles close to the surface was also causing some inaccuracies in the rendered model. It was
determined that some additional image processing would be necessary to obtain a high quality
final healthy model.
The preliminary reconstruction of the healthy model was compared to SEM photographs in order
to obtain the orientation of the slices, and to further pinpoint a region of interest. The region was
selected based upon criteria similar to SEM selection (absence of foreign material, complete
alveolar shape, no air bubbles). The portion selected is highlighted with a white circle in Figure
4.14A, which eliminated the bottom 230 images from the scan (bottom referring to bottom of the
model) reducing the total number of images for further image cleanup to 492. Only this region
would be further processed and cleaned, while the other portions present in the image would be
deleted.
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A preliminary reconstruction was also performed using the top 1,016 slices from the emphysema
lung cast, which again showed evidence of air bubbles and surface impurities. Using the
reconstruction as a basis to determine orientation of the scan axis, a region was chosen for
further image processing (shown in Figure 4.14B). The number of images that were necessary
for processing was reduced to 919.

(A)

(B)

Figure 4.14: (A) The full reconstruction of all 1,261 slices of the healthy 3.58 micron/pixel scan resolution in
VP Sculpt. The white circle shows the region chosen for further image processing and region of the final
healthy model. (B) A reconstruction of the top 1,1016 slices of the emphysemic cast scan in VP Sculpt. The
white circle shows the region chosen for further image processing and region of the final emphysemic model.

4.5 Refine and improve region by image processing in ImageJ
4.5.1 Section Removal
A procedure was adapted after a number of different image processing test trials, consisting of
continuous segmentations and reconstructions. The final procedure consisted of using ImageJ,
an image processing and analysis package developed by the National Institute of Health, to open
the original scanned slices. Using the preliminary reconstruction for orientation, portions of the
image were deleted leaving only the region of interest (Figure 4.15). This procedure was
performed on the healthy and emphysemic sets of scanned images.
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Figure 4.15: ImageJ was used to delete sections of the photo that were not in our region of interest. This
would be beneficial for further reconstructions and reduces the number of nodes and faces. It is shown the
section highlighted in white has been removed. The images shown are from the healthy scan.

After all unnecessary sections were removed, the images were edited to remove features that are
not consistent to in vivo, such as filling in air bubbles near the cast’s surface (shown in Figure
4.16).

Figure 4.16: Holes and air bubbles were filled in to accurately depict the acinus model during reconstruction.
The improvements are shown above by looking at the two portions circled in white. Again, a set of healthy
scan images is shown.

4.5.2 Static Cleanup
Unfortunately, after removing the unnecessary portions and filling in holes and air bubbles, some
additional editing still remained which included reducing the halo and static near the cast’s
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surface. It is visible in Figure 4.17 the effects this static has on the reconstructed model’s surface
and exterior. To help reduce the effects of this unexplained static it was removed in order to
make a more pronounced boundary between the image background and the lung cast cross
section. The procedure for removing this halo included taking a small circle from the image
background, copying, and then pasting it multiple times along the boundary. Particular care was
taken so that the boundary did not change, which insured that no unnatural features would be
added during reconstruction. As was done previously in the Section Removal, this procedure
was performed on both the healthy and emphysema slices.

Figure 4.17: A VP Sculpt screenshot of the emphysemic reconstruction showing the effects of image static on
the reconstructed model’s surface, which led to the decision of additional editing to clean and remove it from
the images.
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4.5.3 Final Model
The final healthy model reconstruction consisted of 368,238 nodes and 736,416 faces after all
static cleanup had been performed on the slices, while the emphysema final model had 1,589,498
nodes and 3,174,083 faces. Figure 4.18 shows the final reconstructions of the healthy model and
the emphysema model in VP Sculpt and how they compare to the actual lung casts. It is
important to note that the microscope picture of the emphysemic cast has been mirrored due to
the image capture device.

Figure 4.18: The final reconstruction in VP Sculpt of the healthy human model (top left) and emphysema
human model (top right) are shown in good comparison to the healthy human lung cast SEM image (bottom
left) and high powered microscope emphysema human lung cast image(bottom right).
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4.6 Geometry Cleanup
4.6.1 Import OBJ to VP Sculpt
After reconstructions took place in 3D Doctor, object files, or .OBJ files, were created for each
of the models and exported to allow an easy transition into VP Sculpt. The first step to cleaning
the models’ surfaces was a series of smoothing operations; each model was smoothed roughly 50
times to eliminate any outlying features. The process of smoothing does not remove or add to
the number of faces or nodes that make up the model’s surface.
Next, decimation took place on each of the models. Decimation is the combining of similar
faces to create larger faces, thereby reducing the model size without losing detail to the surface.
It was necessary to decimate the models four times before the size was reduced enough for
importing to SolidWorks. The healthy human model was reduced to 27,012 nodes and 54,032
faces after decimating, while the emphysemic human model was left to 23,497 nodes and 46,982
faces.
The last step that was required before a duct could be added was to remove any improper, null,
and appended facets and the bow tie and unconnected vertices that may have existed from the
reconstruction or were created during the smoothing and decimation processes. In addition to
removing these features, outer boundaries and holes were filled in order to produce a complete
volume. Figure 4.19 shows the completed models in VP Sculpt after all processing had taken
place and were ready for SolidWorks. Each model was exported from VP Sculpt as a
stereolithography, or .STL, file for compatibility with SolidWorks.
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(A)

(B)

Figure 4.19: The (A) healthy and (B) emphysema models after all operations in VP Sculpt had been
performed and were ready for addition of ducts and alveolar features in SolidWorks. The white circles in (A)
shows the location where the duct and (B) where the additional alveolar features will be added.

4.7 Addition of Inlet Duct (Healthy and Emphysema) and Alveoli
(Emphysema)
SolidWorks, a 3D mechanical CAD software package, was used to create the inlet ducts of the
healthy and emphysemic models, as well as, completing the additional alveolar shapes of the
emphysema model.

4.7.1 SolidWorks Additions
A procedure for creating the inlet ducts of the healthy and emphysema model was developed by
making use of the built in tools from SolidWorks. After importing the .STL file as a Surface
Body, the first step necessary was to choose a location from which the duct would extrude. A
relatively flat region of the healthy model was found to be present and was chosen for the duct
location (white circle in Figure 4.19A). Using points in the flat region to create a plane, the
“Offset Entities” tool was used to create a profile. The profile was lofted to create a transition
region between the duct and acinus. Next, a cylinder was extruded in opposite directions, above
and below the plane previously created. The last step to creating the duct was to perform a series
of lofts and extrudes in order to fill in, or smooth, the new addition to the acinus so that
inaccuracies were not present during future analyses (Figure 4.20).
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Find Duct Location

Loft Entities to Cylinder

Extrude Cylinder Down

Offset Entities and Extrude

Extrude Cylinder

Loft Down to Cylinder

Fill in Missing Sections

Figure 4.20: Procedure for creating duct on the healthy model in SolidWorks shown in picture form, showing
the effects each step has in reaching the final creation. The white circles are used highlight the effects each
step has on the duct creation.

In addition to a duct, the emphysema model required alveolar features to be created in flat
regions. These features were generated in a manner similar to the duct. A series of planes were
created starting at the flat regions (white circles in Figure 4.19B) and progressing away from the
model. Using “Offset Entities”, profiles were formed on each plane in order to form a spherical
cap for each flat in the model (Figure 4.22).
The final step in SolidWorks was to export the newly created duct and alveolar region as a .STL
file so that the additional features and acinus model could be merged together using VP Sculpt.
Although the images in Figure 4.20 may show the duct and acinus together, the additional
features are not connected to the acinus model when created in SolidWorks. The acinus is only
imported so that it can be used as a template or aide for scale and orientation in creating the duct.

4.7.2 Import STL of Additions into VP Sculpt
VP Sculpt is needed for the combining of the duct created in SolidWorks to the cleaned up
acinus created in VP Sculpt. Before the two models could be merged, the duct had to be
translated to the same location as it was created in SolidWorks (Figure 4.21).
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(A)

(B)

Figure 4.21: VP Sculpt screenshot shows the .STL file of the duct is not located properly with the acinus. The
(A) before and (B) after images of translating the duct into the proper position are shown.

Unfortunately, after the duct was moved into its correct place the process was not complete, a
problem occurred where the features intersect. If the two models were merged immediately, the
faces that intersect were not removed and remained inside the model (Figure 4.22). This does
not pose to be a problem immediately; however, when it was necessary to mesh the model in the
future, the internal faces caused negative volumes that did not allow for simulating to take place.
The reason for this is that each model is a surface geometry and is made up of surface nodes and
faces only. It is easiest to think of the models as being hollow.
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Figure 4.22: VP Sculpt screenshots showing how intersecting faces are not removed after two models have
been merged. The white circles highlight regions where internal faces occur after the duct and alveolar
features have been merged to the models by showing a cross section view of the (top row) healthy and (bottom
row) emphysema models.

A procedure was developed for fixing this problem by removing the intersecting faces before the
models are merged. For the healthy model, after the duct was moved to its correct place, the
“Trim Model at Intersection” feature in VP Sculpt was used on the duct and acinus piece,
separately. The two trimmed models were then opened together and merged, however a large
hole, or gap, was still present in the newly merged model that needed to be taken care of (Figure
4.23). It was necessary to create additional facets around the duct and acinus to gap the distance
between the two models before the “Fill All Holes” feature performed the desired operations.
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Figure 4.23: The gap that remains after merging the trimmed duct and
alveolar model is shown in VP Sculpt. The upper left corner is used to
shown the region which is zoomed in upon.

A similar procedure was performed for merging the duct and additional alveolar features on the
emphysema human model. The final models after all merging and cleanup had been performed
are shown in Figure 4.24.

(A)

(B)

Figure 4.24: (A) The completed healthy model is shown after the duct has been added and surface has been
cleaned. (B) The final emphysemic model is shown with additional alveolar features and duct. (Both images
are screenshots from VP Sculpt)
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4.7.3 Model Scaling
One final step was necessary before meshing could take place, the models needed to be scaled
correctly to accurately depict in vivo dimensions. Up until this point an arbitrary unit of measure
had been used that was produced when the model was reconstructed in 3D Doctor. The correct
scaling factor was determined by making use of the SEM and high powered microscope pictures.
The photos were analyzed using ImageJ, by using the scales present in each of the images an
accurate length scale could be generated. For example, using the 1 mm scale in the SEM image
of Figure 4.26, a millimeter to pixel conversion could be created and applied to other dimensions
in the photograph.
The healthy reconstructed model was rotated into a position similar to the microscope photo and
a single dimension was taken and compared for each (Figure 4.25). A scaling factor of 0.00361
was used in VP Sculpt to reduce the healthy model to in vivo size. After scaling the
reconstructed model, a series of three additional measurements were compared between the
reconstructed model and the SEM photo (Table 4.3).

(A)

(B)

Figure 4.25: (A) Microscope picture and (B) VP Sculpt screenshot used to obtain scaling factor from
arbitrary dimensions to in vivo dimensions. The red lines in each image represent the location of the
dimension which was compared.
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Table 4.3: Comparison between ImageJ and VP Sculpt
dimensions after scaling the healthy model by 0.00361.

Length in
ImageJ (mm)
0.247
0.399
0.425

Length in VP
Sculpt (mm)
0.252
0.438
0.425

% Difference
2.03%
9.90%
0.08%

The model and photo showed good agreement; with the blue dimension having an average
difference of 0.08%, the green line having an average percent difference of 2.03%, and the red
line had a slightly higher percent difference of 9.90% (Figure 4.26). However, it can be seen that
for the red line the right side begins to move out of the depth of the field, which could explain
the higher difference.
The scaling factor that was used in the emphysema model was 0.00306, and was obtain using the
same procedure that was performed in the healthy model. Again, good agreement was found
when comparing additional dimensions after scaling; having percent differences of 1.02%,
2.02%, and 13.28% (Figure 4.27 and Table 4.4).

Figure 4.26: SEM photograph of healthy cast used for comparing 3D model scaling
to actual lung cast. The colored lines represent different dimensions that were used
for comparing.
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Table 4.4: Comparison between ImageJ and VP Sculpt dimensions after
scaling the emphysemic model by 0.00306.

Length in ImageJ
(mm)
0.984
2.293
1.686

Length in VP
Sculpt (mm)
0.974
1.988
1.652

% Difference
1.02%
13.28%
2.02%

Figure 4.27: Microscope image of the emphysema cast used for comparing 3D model
scaling to actual lung cast. The colored lines represent different dimensions that
were used for comparing.

Similar to editing the acinus, the final models were cleaned by removing improper facets, etc.
before exporting .STL files for meshing in Harpoon.

4.8 Mesh
Harpoon (Sharc Ltd, Manchester, England) is an automatic hex dominant volume meshing
software tool which is capable of meshing complex geometries that other mesh tools commonly
struggle with. Due to the use of hexagonal elements, convergence and solver time are drastically
reduced making this product a great choice for this application.
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4.8.1 Harpoon to create BC’s and mesh
A .STL file is imported into Harpoon as one complete surface, therefore, the first step before
meshing was to break the single surface into two faces, the inlet and acinus wall. The models
were separated by using the “Separate by…Feature” tool, but only after the Geometry
Preferences Separation Angle had been set to 20. The inlet face was then located and labeled
properly; the remaining faces were merged together to created the acinus wall. Meshing of the
models could now take place.
The mesh settings for Harpoon allow the user to control the surface cell size, maximum volume
mesh size, mesh type, and mesh expansion (Figure 4.28). The surface cell size and maximum
volume size are each functions of the Base Level. Using different settings can allow the mesh to
contain elements all of the same size or a mesh that has smaller elements near the wall and larger
elements in the center (Figure 4.29).

Figure 4.28: Harpoon mesh settings panel
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(A)

(B)
Figure 4.29: Mesh effects of different settings in Harpoon to
obtain a (A) uniform element size or (B) mesh with element
size tighter along boundaries and coarser in the middle of the
model.

The healthy model was meshed using a Base Level of 0.04, a Surface Cell Size of Level 3
(0.01000), and Max Vol Size of Base Level (0.04000), which created 774,380 elements and
627,214 nodes. The Surface Cell Size is approximately 0.6% of the healthy model’s x, y, and z
dimensions, similar to the initial boundary layer height being 0.5% of the radial and axial
dimensions of the tube used in the Chen validation. The Max Vol Size is 2.4% on average of the
model’s dimensions, which compares well with the internal mesh being 2.5% of the Chen tube’s
dimensions.
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The emphysemic model was meshed using a Base Level of 0.025, a Surface Cell Size of Level 2
(0.01250), or 0.4% of the model’s size, and Max Vol Size of Base Level (0.02500), or 0.7% of
the overall size, which created 947,199 elements and 842,689 nodes.
After meshing, each mesh was exported as a surface and volume mesh designated for Fluent.
The final Harpoon meshes are shown in Figure 4.30 and Figure 4.31.

Figure 4.30: Final Harpoon mesh of healthy model exported to Fluent.
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Figure 4.31: Final Harpoon mesh of emphysema model exported to Fluent

4.9 Model Geometry
The healthy human model including the duct addition extends 2.11 mm in the x-direction, 1.34
mm in the y-direction, and 1.74 mm in the z-direction. The total volume of the model is only
1.16 mm3, or 1.16e-3 ml. The inlet duct diameter measures 0.41 mm, which is well within the
limits for a duct in this region of the lung. A series of human lung casts were measured which
reported alveolar duct diameters on average to range from 0.25 to 0.50 mm in the acinus
(Haefeli-Bleuer and Weibel 1988).
The emphysema human model with the additional alveolar features and duct had a total volume
of 12.49 mm3, or 1.25e-2 ml. The emphysema model is 10.8 times larger than the healthy model
by volume. The global size of the model measures 3.74 mm, 3.18 mm, and 3.49 mm in the x, y,
and z directions, respectively. Last, the inlet duct of the emphysema model had a diameter of
0.81 mm. Kohlhaufl et al. (1988) reported an effective airway diameter (EAD) of 0.63 mm,
however an EAD of 0.86 mm was reported by another one of his studies in 1998. The duct
diameter of the emphysemic model falls between the values published.
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5 Chapter 5 Results
5.1 CFD Parameter
The Fine Particle Model (FPM) add on to Fluent, previously discussed in Chapter 3 Theory, was
used to solve the convective-diffusion equation (Equation (3.2)) on each mesh of the healthy and
emphysemic models. A constant inlet concentration of 1e15 particles/m3 was set at each of the
model’s inlets, while the walls were set to remain at a concentration of 0 particles/m3. Two
groups of particles, sizes of 1 nm and 3 nm, were analyzed for a period of 5 seconds by
concentration contours, particle flux (Equations (3.5) and (3.6)), and particle deposition
(Equations (3.8) and (3.9)) for each of the models.
Attempts to simulate larger particle sizes of 8, 10, 30, 100, and 300 nm were unsuccessful due to
the residuals not converging properly which caused negative concentrations to exist inside the
models in some of the cases.

5.2 Concentration Contours in Healthy and Emphysema Models
The unsteady concentration contours in the healthy model were all taken at a x-y plane located in
the center of the inlet duct. The unsteady concentration contours shown below for the
emphysema model are also located at the center of the inlet duct. Figure 5.1 shows the
concentration contours for the 1 nm group of particles in the healthy (A, C, and E) and
emphysematous (B, D, and F) models at three points in time during the simulation period. The
first two times were chosen arbitrarily, while the last point in time (Figure 5.1(E and F)) was
chosen to be steady state. No change was found to occur in the contours of the healthy model
after about 0.08 seconds (Figure 5.1(E) and Figure 5.5). The concentration contours in the
emphysemic model stopped changing after roughly 0.17 seconds (Figure 5.1(F) and Figure 5.6).
It is important to note that the scale is consistent among each of the images and that regions
showing blue simply mean the concentration is lower than the minimum value of the scale.
Figure 5.1(A and B) shows the concentration contours of the healthy and emphysemic models at
the same point in time early in the simulation. It is easy to see that the particles have been able
to diffuse deeper into the healthy model over the same period of time. Figure 5.1(C and D) show
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similar concentration contours, however, the simulation time of the emphysemic model is 6
times that of the healthy model, again displaying the increased diffusion time.

(A)

(B)

(C)

(D)

(E)

(F)

Figure 5.1: Concentration contours in the (A, C, and E) healthy and (B, D, and F) emphysematous models for
three points in time of the 1 nm simulations. The healthy cross sections were taken at z=0.34 mm and the
emphysemic cross sections were taken at z=-1.34 mm. (E) and (F) correspond to steady state in each case.
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Figure 5.2 shows concentration contours for the 3 nm group of particles at three points in time
for the healthy (A, C, and E) and emphysemic (B, D, and F) models. The healthy 3 nm
concentration contours were found to have no changes after approximately 0.26 seconds (Figure
5.2(E)), while the emphysemic model took nearly 0.5 second Figure 5.2(F) before contours
became steady.
An important finding can be seen when viewing the steady state healthy images (Figure 5.1(E)
and Figure 5.2(E)) and the steady state emphysematous images (Figure 5.1(F) and Figure
5.2(F)). As expected, the steady state concentration contours are the same for each model even
though the particle sizes that were released at the inlet were different. Looking back to Equation
(3.2) in Chapter 3, at steady state the diffusion coefficient no longer contributes to the solution of
the concentration. Therefore explaining why the concentration contours for any size particle will
look the same at steady state. The total particle deposition, which is based up on particle flux,
will not be the same for different particles due to the diffusion coefficient’s presence during
calculations. Since steady state is reached relatively quickly in all cases, for further analyses
only the steady state solution will be reviewed. The accuracy of this assumption is discussed in
Section 5.7.
The healthy model has been broken down into six planes, spaced equally, 0.248 mm, throughout
the z-axis (Figure 5.3). Plane #2 was located in the center of the duct. Similarly, the
emphysemic model has been sectioned six times, 0.499 mm, over the span of the z-axis (Figure
5.4), with plane #6 located at the duct’s center. A better view of the steady state solution in the
healthy model, showing the global distribution of concentration in each plane throughout the
model, can be viewed in Figure 5.5. An isometric view of each of the planes combined is shown
in Figure 5.7(A). Figure 5.6 shows the concentration contours in each of the six emphysemic
planes, which are joined into a single isometric view in Figure 5.7(B).
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(A)

(B)

(C)

(D)

(E)

(F)

Figure 5.2: Concentration contours in the (A, C, and E) healthy and (B, D, and F) emphysematous models for
three points in time of the 3 nm simulations. The healthy cross sections were taken at z=0.34 mm and the
emphysemic cross sections were taken at z=-1.34 mm. (E) and (F) correspond to steady state in each case.
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Figure 5.3: (A) Isometric view and (B) top view of the six planar locations analyzed in the healthy model in
Figure 5.5 and Figure 5.7. The distance between each plane is 0.248 mm, while the plane #2 is located at
z=0.34 mm.
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Figure 5.4: (A) Isometric view and (B) top view of the six planar locations analyzed in the emphysemic model
in Figure 5.6 and Figure 5.7. The distance between each plane is 0.499 mm, while the plane #6 is located at
z=-1.30 mm.
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(1)

(2)

(3)

(4)

(5)

(6)

Figure 5.5: Contours showing the global distribution of concentration throughout the healthy model.
(Numbers correspond to the planes shown in Figure 5.3)
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(1)

(2)

(3)

(4)

(5)

(6)

Figure 5.6: Contours showing the global distribution of concentration throughout the emphysematous model.
(Numbers correspond to the planes shown in Figure 5.4)
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(A)

(B)

Figure 5.7: Isometric views of the concentration contours for the equally spaced six
planes in the (A) healthy and (B) emphysemic models.
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5.3 Particle Flux in Healthy and Emphysema Models
The particle flux at the inlet and wall (Equations (3.5) and (3.6)) was calculated after the
convective-diffusion equation had been solved based upon Equation (3.1), by summing over the
area of the inlet or wall. The particle flux was analyzed using a custom user defined function
(UDF) for Fluent and FPM, which was designed to automatically output the inlet and wall flux to
a text file after each time step of the simulation. The UDF code can be found in Appendix A –
UDF Code. The plots shown are based on this flux output. Note that since the wall flux
originally is negative when output from FPM, because the particles are exiting the model and
traveling in the direction opposite to the normal of the wall, they were made positive before
plotting. For comparison purposes, the inlet concentrations for each model and each particle size
were kept at 1e15 part/m3.

5.3.1 Healthy
The inlet and wall fluxes for both the 1 nm and 3 nm simulations are shown to converge very
quickly upon one another (Figure 5.8). It is difficult to see but the inlet flux for the 1 nm
solution starts at approximately 1.5E+08 particles/s, while the wall flux starts near 3.4E+06
particles/s. Each is shown to converge quickly to a value of 1.6E+07 particles/s. The 3 nm
solution’s inlet flux starts around 2.0E+07 particles/s with the wall flux beginning at nearly
1.0E+05 particles/s. The fluxes for this solution quickly settle around 1.8E+06 particles/s.
Figure 5.8 helps to view just how quickly the fluxes converge by showing the first 0.01 seconds
of each healthy simulation.
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Particle Flux in Healthy Model

4.0E+07

Inlet (1nm)
Wall (1nm)
Inlet (3nm)
Wall (3nm)
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2.0E+07
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0.0E+00
0
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Time (s)
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Figure 5.8: Plot showing initial 0.01 seconds for the inlet and wall fluxes. The 1 nm and 3nm simulation
results have been combined and shown for the healthy model. The 1 nm inlet flux has been cut off in the
beginning to help portray the overall trend of all of the lines. Inlet concentration of 1E+15 particles/m3.

5.3.2 Emphysema
Similar to the healthy solutions, the inlet and wall fluxes for the two emphysemic simulations
have been shown for both the 1 nm and 3 nm cases in Figure 5.9. The inlet and wall fluxes for
the group of 1 nm particles start near 3.7E+08 and 3.3E+06 particles/s, respectively, and
progress towards the steady state flux of around 3.3E+07 particles/s. The 3 nm solution inlet and
wall fluxes start off lower, possessing values of 4.6E+07 and 1.3E+04 particles/s, respectively.
Each took slightly more time than the comparable healthy simulation to approach one another
before reaching the final flux value of 3.7E+06 particles/s. Neither of the simulations has
completely converged at this point in the simulation, but it’s quite apparent that it will occur
shortly after based upon the shown trends.
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Particle Flux in Emphysema Model

1.0E+08
Particle Flux (Particles/s)

9.0E+07
8.0E+07
7.0E+07

Inlet (1nm)
Wall (1nm)
Inlet (3nm)
Wall (3nm)

6.0E+07
5.0E+07
4.0E+07
3.0E+07
2.0E+07
1.0E+07
0.0E+00
0

0.002

0.004

Time (s)

0.006

0.008

0.01

Figure 5.9: Plot showing initial 0.01 seconds for the inlet and wall fluxes. The 1 nm and 3 nm simulation
results have been combined and shown for the emphysema model. Inlet concentration of 1E+15 particles/m3.

5.4 Deposition in Healthy and Emphysema Models
The total particle deposition in the healthy and emphysemic models was obtained using the wall
flux output and summing it over the period (Equation (3.8)). The measure of “total number of
particles deposited” is typically used for inhaled medication (Figure 5.10), and is associated with
the amount of translocation to the blood stream; however “particles per unit of surface area” is
more commonly used for toxicity (Figure 5.11) since it is a representation of the toxic loading on
the individual cells. The values in each of the figures vary only by the surface area of the
model’s wall: 1.05E-05 m2 for the healthy model and 3.36E-05 m2 for the emphysemic model.
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Particle Deposition in Healthy and Emphysema Models
3.0E+05
Emphysema (1nm)

Deposition (Particles)
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Healthy (1nm)
Emphysema (3nm)
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Time (s)

0.006

0.008
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Figure 5.10: Plot showing the deposition of particles in the healthy and emphysemic models for particle sizes
of 1 and 3 nm over a 5 second period.

Particle Deposition per Area in Healthy and Emphysema
Models
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Figure 5.11: Plot showing the deposition of particles per surface area in the healthy and emphysemic models
for particle sizes of 1 and 3 nm over a 5 second period.
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The percent deposition, or deposition efficiency, of particles was calculated by taking the ratio of
the number of particles deposited over time (Figure 5.10) to the number of particles that entered
over that time, as shown in Equation (3.10). Figure 5.12 displays the percent deposition for
groups of 1 nm and 3 nm particles in the healthy and emphysemic models over a 2 second
period. In both models, the 1 nm cases approaches steady state conditions before the 3 nm cases.

Compare Deposition Efficiency for H and E Models
100%
Percent Deposition (%)

90%
80%
70%
60%

Healthy (1nm)

50%

Healthy (3nm)

40%

Emphysema (1nm)

30%

Emphysema (3nm)

20%
10%
0%
0

0.05

0.1

0.15
Time (s)

0.2

0.25

0.3

Figure 5.12: Plot showing the percent deposition of particles entering the healthy and emphysemic models for
particle sizes of 1 and 3 nm over a 2 second period, which shows the efficiencies to have converged to steady
state.

5.5 Comparison to in vivo Pulmonary Deposition Data from the Literature
Although there is no experimental evidence for particle sizes analyzed in this study, some
conclusions can be drawn based upon some of the past studies. Figure 5.13 shows all of the
experimental data that was outlined in Section 2.6.
In order to compare our results to experimental data, we determined the pulmonary deposition
from particles that entered the pulmonary region during the brief pause time between inhale and
exhale. Table 5.1 gives the pause times, for a pause cycle fraction of 4.9%, for three breathing
frequencies, and the local alveolar deposition fraction at those pause times, predicted from our
model. These breathing frequencies were chosen to represent the range used for the in vivo
deposition studies.
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Furthermore, in order to compare these values to the in vivo data, we must first account for
filtering in the TB region. The particles depositing in the TB region never make it to alveolar
region, and therefore must be removed from the total fraction of particles entering. To account
for the TB filtering in the in vivo data, it was necessary to determine the deposition fraction of
the TB region so that this could be subtracted out of the deposition fraction that enters the
alveolar region. After knowing the deposition fraction of particles entering the alveolar region,
the new deposition fraction could be obtained by taking the ratio of the fraction of particles that
deposited to the fraction of particles that entered. Figure 5.13 shows the local alveolar
deposition fractions for the experimental in vivo studies, along with the local alveolar deposition
results from the healthy and emphysema simulations. Note that Stahlhofen et al. (1980) did not
provide TB data and therefore is not included in Figure 5.13. It is difficult to draw any real
conclusions from this data due to the large disconnect between particle sizes, perhaps additional
studies using smaller particles could help contribute in the future.

Local Alveolar Depostion Compared to in vivo Healthy Data
1.00
0.90
Deposition Fraction

0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
0.001

Lippmann and Albert (1969)
Emmett et al. (1982)
Kim and Jaques (2000)
Healthy Simulation
Emphysema Simulation
0.01

0.1

1

10

Particle Diameter (µm)
Figure 5.13: Plot showing the local alveolar deposition fraction vs. particle diameter for experimental in vivo
studies and the healthy and emphysema simulations. (Triangles, squares, and circles correspond to pause
times of 0.294, 0.196, and 0.134 seconds, respectively, while black and orange correspond to healthy and
emphysema, respectively.)
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Table 5.1: Pause times and local deposition fractions from this study at pause times for four breathing
frequencies.

Local Deposition Fraction (this study) at different
Pause Times
1 nm
3 nm
Breathing
Frequency
(breaths/min)
10
15
22

Pause
Time
(sec)
0.294
0.196
0.134

Healthy

Emphysema

Healthy

Emphysema

0.96
0.95
0.95

0.93
0.92
0.92

0.94
0.93
0.91

0.84
0.81
0.77

5.6 Comparison to Other Model Studies in Literature
As reviewed in Section 2.3, there are deposition models that have been developed for simulating
the particle deposition in each generation of the lung based upon straight tube assumptions and
average lung geometries. These models do not include closed-ended tubes or geometry similar
to in vivo alveolar shapes, while others only look at deposition during inspiration. Using these
deposition models, simulated particle deposition can be obtained for very small particles, similar
to the scale in this study. As a method of validation, each model was compared against another,
which showed good agreement.
The deposition fractions shown in Figure 2.10 are relative to the amount of inhaled particles.
Similar to the in vivo experimental studies, these can be converted to local alveolar deposition
fractions in order for the healthy and emphysema simulation results to be compared. For the
MPPD model, deposition fractions from generations 1 through 13 were added together to
account for deposition in the TB region of the lung. The remaining fraction of particles was
assumed to enter the alveolar region. Deposition fractions for generations 14 through 24 were
summed to obtain the alveolar deposition fraction. The ratio of the two deposition fractions,
fraction of particles remaining to fraction of particles deposited, was considered to be the local
alveolar deposition fraction. For example, for 0.005 µm particles, the sum of the MPPD model’s
TB deposition fractions (1-13) were 0.1, the summed alveolar deposition fraction (14-24) was
0.44. Therefore, only 90% of the particles were able to reach the alveolar region. Therefore, the
local alveolar deposition fraction becomes 0.44/0.9; a fraction of 0.55 or 55%. A similar
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procedure was performed on the results output for the Trumpet model. Figure 5.14 shows the
comparison of local alveolar deposition of the two whole lung models and the healthy and
emphysema model at the three previously discussed pause times. Similar to the in vivo
experimental results, there is very little agreement between the two models and our results.
Although these models have not been validated experimentally for nanoparticles, Scherer et al.
(1972) presents two models, one analytical and one numerical, for N2, which has a diameter on
the same order of magnitude as our simulations. Scherer’s models were shown to have relatively
good agreement with experimental results. The solutions from the MPPD and Trumpet models,
shown in Figure 5.14, are based upon the theory of Scherer’s solutions.

1

Local Alveolar Depostion Predictions Compared to Healthy
Whole Lung Model Predictions
Healthy Simulation
Emphysema Simulation
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Figure 5.14: Local alveolar deposition of whole lung models and the 1 and 3 nm healthy and emphysemic
simulations. (Triangles, squares, and circles correspond to pause times of 0.294, 0.196, and 0.134 seconds,
respectively, while black and orange correspond to healthy and emphysema, respectively.)

The healthy and emphysemic whole lung models presented in the work of Sturm and Hofmann
(2004), showed similar trends in alveolar deposition as the Trumpet and MPPD models. The
data shown in Figure 5.15 is for overall alveolar deposition, and not local alveolar deposition that
has been shown thus far. It was determined that particle deposition was greater in the healthy
lung model by approximately 7% when compared to the emphysema models. The trends of our
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results agree with Sturm and Hofmann, which found the deposition efficiency in the healthy
model to be 96% in both cases and in the emphysema to only be 93% and 94% for the 1 and 3
nm cases, respectively.

Figure 5.15: Percent alveolar deposition results for healthy and emphysema whole lung
models. (Sturm and Hofmann 2004)

5.7 Accuracy of Steady State Assumption
As previously discussed, the healthy simulations quickly approach steady state, which means the
rate of deposition of particles with respect to time becomes constant after only a short period of
time. This is evident in the particle deposition plots as they become nearly linear with respect to
time very quickly. Assuming steady state deposition over the entire breathing period provides
the opportunity to simplify the numerical simulations. Steady state was assumed to occur when
the change in the deposition efficiency curve became less than 0.1% per second (Figure 5.16.
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Figure 5.16: Slopes of percent deposition curves from Figure 5.12. Red line shows the criterion used to
determine when steady state has occurs.

Table 5.2: Criteria for reaching steady state based on different model results

Steady State (SS)
Values
SS Deposition (%)
SS Time (s)

1 nm
Healthy
Emphysema
96%
0.08

94%
0.17

3 nm
Healthy Emphysema
96%
0.26

93%
0.49

The time frame for each model to reach steady state is provided in Table 5.2. The 1 nm healthy
simulation approached steady state at 0.08 sec. During this time, an unsteady solution predicts a
deposition of 1.28E+06 particles, while the steady state solution (using the steady state wall flux
of 1.64E+07 particles/s) predicts a deposition of 1.29E+06 particles, an increase of 6350
particles, or a 0.50% over estimation. Therefore, it is clear that the error associated with the
steady state assumption is relatively small. If this over-estimation in 1 nm particle deposition is
compared to the 1 nm particles deposited over 1 second (1.64E+07 particles) or 5 seconds
(8.19E+07 particles), the total over-estimation is 0.04% and 0.01%, respectively. These values
and the associated errors for the other 3 model cases are shown in Table 5.3. The worst case is
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the 3 nm in E, which gives errors of 4.12% at the steady state time of 0.49 sec, and 1.98% and
0.39% at 1 and 5 seconds, respectively.
Table 5.3: Error introduced when assuming steady state for entire breathing period.

SS time (seconds)
Unsteady Deposition
(Particles)
Deposition using Steady
State Assumption (Particles)
% Error at SS time

Healthy (H)
1 nm
3 nm
0.08
0.26

Emphysema (E)
1 nm
3 nm
0.17
0.49

1.28E+06 4.69E+05 5.24E+06 1.63E+06
1.29E+06 4.75E+05 5.30E+06 1.69E+06
0.50%

1.46%

1.06%

4.12%

Deposition at 1 second
% Error at 1 second

1.64E+07 1.82E+06 3.11E+07 3.39E+06
0.04%
0.38%
0.18%
1.98%

Deposition at 5 seconds
% Error at 5 seconds

8.19E+07 9.14E+06 1.56E+08 1.72E+07
0.01%
0.08%
0.04%
0.39%

If we assume that all pulmonary deposition takes place during the pause between inhalation and
exhalation, it is of interest to determine what proportion of the pause is characterized by unsteady
state deposition relative to steady state. To do this, we provide Table 5.4, which gives the
fraction of unsteady state (change in deposition efficiency > 0.1% per second) to the total pause
time for various breathing frequencies for a pause cycle fraction of 4.9%. It can be seen from
Table 5.4 that steady state behavior dominates for all breathing frequencies of 1 nm healthy, but
only 12 and 15 breaths/min for the 1 nm emphysema case. Unsteady behavior is 50% or more of
the pause time for all 3 nm emphysema cases.
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Table 5.4: Ratios of time to reach steady state to pause time for four breathing frequencies.

1 nm

3 nm

Breathing Frequency
(breaths/min)

Pause
Time (sec)

Healthy

Emphysema

Healthy

Emphysema

12
15
20
22

0.25
0.20
0.15
0.13

0.32
0.40
0.53
0.59

0.69
0.87
1.16
1.27

1.06
1.33
1.77
1.95

2.00
2.50
3.33
3.67

5.8 Extrapolated Particle Deposition
It was previously demonstrated (Section 5.2) that the steady state concentration contours are
independent of particle size. Therefore, the steady state concentration gradients found for the 1
and 3 nm particles, in this work, can be used to extrapolate steady state wall flux for any other
size particle. The following calculation, demonstrates that theoretically, the steady state solution
for the integral of div C over the surface area, is independent of particle size. Using Equation
(3.5), this value can be solved for as follows:
For the 1 nm particle,

particles
1.64E+07
s

m2
5.32E-06
s

1.64E+07
5.32E-06

3.08E+12

particles
m2

where A is the wall area. And the same value is found for the 3 nm particle,

1.83E+06

particles
s

5.94E-07

1.83E+06
5.94E-07

m2
s

3.08E+12

particles
m2
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The integral of div C over the area for the emphysema model was calculated (using the values
shown in Table 5.5) to be 5.86E+12 particles/m2. Steady state deposition rates in the healthy and
emphysema model can be found for other particle sizes by making use of Equation (3.5). Table
5.6 gives a range of particle sizes and the diffusion coefficients (D) for each. Figure 5.17 shows
the resulting steady state deposition rates (particles/s) for various particles in both models by
taking the corresponding div C integral and multiplying by the diffusion coefficient of different
particles. If the deposition rate is known, then the total number of deposited particles can easily
be obtained by integrating over the desired time period (Figure 5.18). Figure 5.19 shows the
deposition rate per unit area in the healthy and emphysemic model by dividing by the wall area
for each model.
Steady date deposition rates for the healthy and emphysemic models show a decreasing trend as
particle sizes increases, as expected due to the particle’s diffusion coefficient become smaller as
particle size increases. The deposition rate is shown to be greater in the emphysema model in
comparison to the healthy model, which is likely due to the increase in alveolar wall surface area
for the particles to deposit. After the area component is removed from the deposition rate values,
the healthy deposition rate is greater than the emphysemic rate.
Table 5.5: Values used to calculate value of steady state concentration gradients for deposition extrapolation.

Healthy
1 nm
3 nm
SS Wall Flux - J'wall
(Particles/s)
Diffusion Coefficient - D
(m2/s)
(Particles/m2)

Emphysema
1 nm
3 nm

1.64E+07 1.83E+06 3.12E+07 3.48E+06
5.32E-06

5.94E-07

3.08E+12

5.32E-06

5.94E-07

5.86E+12
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Table 5.6: Particle diameters and corresponding diffusion coefficients.

Particle Diameter
(µm)
0.001
0.003
0.008
0.01
0.02
0.03
0.08
0.09
0.1
0.2
0.3
1

D (m2/s)
5.32E-06
5.94E-07
8.46E-08
5.45E-08
1.40E-08
6.39E-09
1.03E-09
8.34E-10
6.94E-10
2.23E-10
1.23E-10
2.74E-11

Deposition Rate (Particles/s)

Compare H and E Particle Depostion Rate
1.0E+08
1.0E+07

Healthy Model

1.0E+06

Emphysema Model

1.0E+05
1.0E+04
1.0E+03
1.0E+02
1.0E+01
1.0E+00
0.001

0.01

0.1

1

Particle Size (µm)
Figure 5.17: Deposition rate to the wall for various particle sizes in healthy and emphysemic models. Inlet
concentration of 1E15 particles/m3.
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Compare H and E Particle Loading in the Lung
Deposition (Particles)

100000
10000

Healthy (0.01 µm)
Healthy (0.1 µm)

1000

Healthy (1 µm)
Emphysema (0.01 µm)

100

Emphysema (0.1 µm)

10

Emphysema (1 µm)

1
0

0.1

0.2

0.3

Time (s)

Deposition Rate per Area
(Particles/m2s)

Figure 5.18: Particle deposition vs. time for 0.01 (purple), 0.1 (red), and 1 (green) µm diameter particles in the
healthy (solid) and emphysema (dashed) models.

Compare H and E Particle Deposition Rate per
Area
1.0E+12
1.0E+10
1.0E+08
1.0E+06
Healthy

1.0E+04

Emphysema

1.0E+02
1.0E+00
0.001

0.01

0.1

1

Particle Size (µm)
Figure 5.19: Deposition rate per unit area for various particle sizes.
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6 Chapter 6 Discussion and Conclusion
6.1 Healthy versus Emphysema
On average the global extents, or overall dimensions of the healthy model are half of the
emphysema model, which correlates to the healthy alveolar model being approximately 11 times
smaller than the emphysema model in size, based upon volume (Table 6.1). Due to the increase
size of the emphysematous model, the wall surface area is more than three times greater than the
healthy, creating a larger region for particles to deposit. The dimensions are in the range of
measured data by Kohlhaufl et al. (1998), which reported an effective airway diameter of 0.86
µm for emphysema. The healthy dimensions are well within the range previously reported by
Weibel (1964).
Table 6.1: Geometry comparisons between healthy and emphysema models X, Y, and Z are the overall
dimensions of the model if it were to be contained in a box.

X (mm)
Y (mm)

Model Comparison
Healthy Emphysema
2.11
3.74
1.34
3.18

Z (mm)
Duct Diameter
(mm)

1.74

3.49

0.41

0.63

Wall Area (mm2)

10.46

33.56

Volume (mm3)

1.16

12.49

Keeping the models constant, the 1 nm particles are shown to deposit at a rate almost an order of
magnitude higher than that 3 nm particles (Table 6.2). Based purely on their diffusion
coefficients, this result is well within expectations.
When the particle size is kept constant, and models are compared, the deposition rate of 1 nm
particles on the wall of the healthy model, 1.64E+07 particles/s, was almost half that of the
emphysema model, 3.12E+07 particles/s, similar results were found in the 3 nm simulations.
Based on Equation (3.5) to calculate the wall flux, the concentration gradient is summed over the

107

entire wall, therefore this result is not surprising since the area for particles to deposit is three
times larger in the emphysema model.
The results reverse when the affect of surface area from the models is taken out of the deposition
rate values. Now, the healthy deposition rate per area (1.57E+06 particles/m2s) becomes greater
than the emphysema deposition rate per area (9.29E+05 particles/m2s) for the 1 nm simulations.
The 3 nm numbers for comparison are shown in Table 6.2, which shows the healthy deposition
per area to be approximately 40% higher than emphysema.
The unsteady state deposition efficiency for the emphysema model is less than for the healthy
model. This trend agrees well with numerical results presented by Sturm and Hoffmann (2004),
who found particle deposition in healthy models to be greater than emphysema models of similar
size. In addition, our results are consistent with decreased deposition in animal models with
emphysema (Damon et al. 1983, Lundgren et al. 1981, Martin et al. 1980, Hahn and Hobbs 1979,
Mauderly et al. 1990).
The steady state deposition efficiencies for the healthy and emphysemic models should approach
100% after infinite time. Based on a simple control volume, if steady state has been reached in
each of the models regardless of particle size, the rate of particles entering must be equal to the
rate of particles depositing in order for mass to be conserved. But the efficiencies shown here
represent our steady state approximation (taken at our steady state criteria) and are therefore less
than 100%. However, the trend does hold; smaller particles will become steady state before
larger particles (96% and 94% for 1 nm and 3 nm, respectively.) and smaller models will reach
steady state sooner than large models ( 94% for H and 93% for E).
Table 6.2: Healthy vs. Emphysema simulation results for comparison

Deposition Rate (particles/s)
Deposition Rate per Area
(particles/m2s)
Steady State Deposition Efficiency
(%)

Healthy vs. Emphysema Comparisons
1 nm
3 nm
Healthy Emphysema Healthy Emphysema
1.64E+07 3.12E+07 1.83E+06 3.48E+06
1.57E+06

9.29E+05

1.75E+05

1.04E+05

96%

96%

94%

93%
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6.2 Comparison to Experimental Data
In order to provide an accurate comparison between the simulations done in this work and
experimental alveolar deposition, a residence time used for particle deposition was determined
by the pause fraction (4.9%) of a single period. This is likely to produce an underestimate in
deposition since this is the very least amount of time that the particles will remain in this region
of the lung. Other considerations had to be taken to ensure an accurate comparison was taking
place, to do this a local alveolar deposition fraction was calculated. The local alveolar deposition
fraction was found my taking the percentage of particles that deposit in the alveolar region, and
dividing by the total percentage of particles that entered this region. In order to determine the
number of particles entering the alveolar region, the tracheobronchial contribution to particle
deposition had be accounted for and subtracted out. This was all necessary because the only data
available from the simulations was particles entering the model and particles depositing, which
were used to calculate a deposition fraction. Even after these corrections, our deposition
predictions for 1 nm and 3 nm particles are higher than expected based on conventional beliefs.
No experimental studies exist for particle sizes on the scale of this research, therefore, it is
required to predict deposition and conclude on expectations based upon the experimental results
that are available. Alveolar deposition studies performed by Lippmann and Albert (1969) and
Emmett et al. (1982) are difficult to interpret due to the wide range of deposition data, no
particular trend is shown to occur that can be applied to particles smaller than 1 µm. However,
the results from Kim and Jacques (2000) produce an easy to see trend. As expected, the particle
deposition increases with smaller sized particles, likely due to the increased ability to move by
molecular diffusion. Similar results were found to occur in this study, as the particle size
decreased the deposition fraction increased. If a straight line were to be extended through the
experimental data to continue the current trend, it would certainly come close to intersecting the
simulation data plotted for the 1 and 3 nm simulations. However, as discussed in the next
section, some modeling data suggests that the trend is a decrease in deposition for decreasing
size in the nanoparticle range. But again, these conventional beliefs are not yet supported by
experimental evidence.
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6.3 Comparison to Whole Lung Models in the Literature
Scherer et al. (1972) were some of the first researchers to present the trumpet model in literature.
Analytical and numerical models were created to predict pulmonary gas washout, which was
later compared to experimental data. Each model solved a form of the convective diffusion
equation, but many assumptions were needed to do so, some included 1D axial flow (1D
convection and diffusion), infinite cross sectional area at the alveoli, and radial mixing is rapid in
comparison to axial mixing. Due to the 1D assumption, no radial diffusion exists and the model
does not take into account any wall losses throughout the path from the 1st to 23rd generation.
Based on this model, nanosized gas particles would make their way right into the alveoli, and
therefore high deposition of nanosized particles in the pulmonary region are possible as we
predict in this study. Scherer’s analytical model showed relatively good agreement with
experimental for nitrogen gas (0.3 nm sized molecules) washout results presented by Shepard et
al. (1957).
The predictions of our study did not agree with the whole lung deposition models, Trumpet and
MPPD. The paradox, is that these whole lung particle deposition models are based on the same
principals as the model derived from Scherer et al. (1972), but some changes were made. MPPD
and Trumpet models solved the convective diffusion equation, using similar assumptions of 1D
axial flow but with no axial diffusion. Neither Trumpet nor MPPD model accounted for direct
radial diffusion, assuming well mixed, however, unlike Scherer (1972) they did account for
losses at the walls. They allowed for the particles to deposit according to the straight tube
diffusion deposition efficiency equations (Ingham 1975) in the TB airways and in the alveoli.
The alveoli were represented as a tube with the generational average duct diameter and radius.
These deposition efficiency equations were derived for a straight tube, with no axial diffusion;
resulting in an overestimated deposition of nanosized particles, so axial diffusion was not
accounted for in particle transport or deposition. Later, axial diffusion was added to the
analytical solution of the convective diffusion equation to enhance particle transport along the
airways (Asgharian and Price 2007). They reported that axial diffusion had an impact on
pulmonary deposition for particles greater than 10 nm, but smaller particles were found to be
completely filtered out by deposition in TB region. This study used the original Ingham (1975)
deposition efficiency equations to represent the loss term in the convective diffusion equation,
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axial diffusion was not completely accounted for. Therefore deposition of smaller particles in
the TB region may be over estimated, reducing transport to the distal. This could be evidenced
in their comparisons to experimental results of Kim and Jaques (2000) for particle sizes 1 to 100
nm. For all sizes, deposition predictions in the pulmonary region were smaller than experiment.
It is necessary to incorporate axial diffusion in deposition efficiency equations in order to
investigate this further.
Using Ingham’s analytical solutions for deposition efficiency in a straight tube, possessing
similar dimensions to an alveolar duct and velocity relevant for this region, deposition
efficiencies of 100% are found for 1 and 3 nm particles, which agree well with our predictions.
It is not clear why these large efficiencies in a single airway do not translate to large efficiencies
in the pulmonary region of the MPPD or Trumpet models. However, this discrepancy is
consistent with an over-estimation of TB deposition and an underestimation of axial transport.
The trends from the stochastic healthy and emphysemic whole lung models used by Sturm and
Hofmann (2004) are very similar to the Trumpet models, in the fact alveolar deposition fractions
approach zero for 1 and 3 nm particles. Unfortunately the agreement with Trumpet means a
disagreement with the results found in this study. Since they had different TB regions for
different diseases, the differences between healthy and emphysema could be in the TB or
pulmonary regions. However, Sturm and Hofmann (2004) found their healthy model deposition
to be 7% higher than the emphysema or diseased models; this was relative to inhaled particles.
In this study, the healthy deposition efficiency was found to be 2-3% higher in the healthy model
compared to the emphysema model, which is relative to local particles. The MPPD model is not
valid for particles less than 0.01 µm but agrees with Trumpet and Sturm and Hofmann (2004) for
larger particles.
In summary, although our model agrees qualitatively well with Scherer (1972), little agreement
is shown to occur between the MPPD or Trumpet deposition predictions and the numerical
results from this study. MPPD does not claim to be valid for particles less than 10 nm. We
expect that the lack of axial diffusion in MPPD and Trumpet is under predicting nanoparticle
transport to the alveolar region. Furthermore, the deposition efficiency equation used in the
MPPD and Trumpet models neglects axial diffusion, which will over estimate TB deposition,
further reducing predictions of alveolar deposition. Our model agrees well with the emphysema
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model presented by Sturm and Hofmann (2004), which predicts lower deposition in E compared
to H, and to experimental in vivo animal data for emphysema.

6.4 Limitations
Some limitations exist in this study which are further discussed here along with their effects on
the overall results.

6.4.1 Boundary conditions
The inlet boundary condition used in this simulation may not be representative of in vivo
conditions in the alveolar region of the lung. In order to determine the particle inlet flux (rate of
particles entering, particles/s), the deposition of particles throughout the other regions of the lung
and mouth must be known precisely. This requires modeling of the TB region and all of the
bronchioles distal to the TB region. Additional difficulty is introduced because the rate would
change with different particle sizes. This alveolar model can now be combined with previous TB
region models to better predict alveolar deposition if this parameter was known.
In this study, the inlet particle concentration (particles/m3) was set to be constant so that the
effect of the alveolar region geometry could be isolated for comparative purposes between the
two models. Keeping the particle size constant, by setting the inlet concentration equal between
the models, the inlet flux of the each model differs.
The inlet duct of the healthy model has a diameter of 0.41 mm, while the emphysema model has
an inlet duct of 0.63 mm, resulting in an area increase of 236% to allow particles to enter. If the
model volume, or geometry, is kept constant, the dispersion of particles for the same
concentration of 1 and 3 nm particles will be vastly different. Based on diffusion coefficient
alone, the rate at which 1 nm particles diffuse is over 10 times greater than that of 3 nm particles,
which would again change the inlet flux for different particle sizes. Therefore, even though the
particle volume concentration (particles/m3) is the same for each model and particle size, the
inlet flux (particles/s) into the model is different because the flux is calculated based upon both
model geometry (div C) and particle diffusivity (D). We believe that keeping the particle
volume concentration constant makes for a better comparison between models than keeping the
flux constant between models. This assumes that the airways proximal to the alveoli are
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identical for both H and E. Ideally, the concentration at the mouth is held constant between
models, and the concentration entering the alveoli would be a function of TB filtering, which
could be altered to represent disease.
It is clear this difference in inlet flux between the two models, H and E, would have no factor in
the solution for concentration at steady state, as long as the inlet concentration boundary
conditions remained the same. Based upon the criteria used for determining steady state (change
in % deposition < 0.1%), the steady state times were consistently smaller for cases where the
inlet flux was higher. It is unknown whether constant concentration causes a difference in flux
that is positive or negative since the flux used for comparison is arbitrary; however, trends show
that a higher inlet flux reaches steady state faster. Therefore, smaller particles will reach steady
state faster than larger particles.

6.4.2 Convergence Issues
This study was limited to only two particle sizes, 1 nm and 3 nm. Multiple attempts to simulate
larger particles were taken, which produced unsatisfactory residual convergence. The lack of
convergence caused negative concentrations and fluxes to occur in the solution, which were
inaccurate. Due to steady state being reached almost immediately, it was assumed to apply
steady state conditions for the entire period of interest, even with particle sizes as small as 1 and
3 nm, the error induced by this assumption was no greater than 4.1%. Using the steady state wall
flux for extrapolation, the deposition rate for any particle size can be obtained.
Some important conclusions can be drawn from the extrapolated steady state results. First of all,
since the results are taken at steady state, the rate of particles depositing is equal to the rate of
particles entering, so the inlet flux is also known. Using the trends discussed in the previous
section 6.4.1, for the same model, smaller particles would reach steady state faster because the
inlet flux is greater.

6.4.3 Non-Expanding Alveoli
Our previous work has shown diffusion to be the dominant mechanism of particle motion in the
alveolar region for particle sizes ranging from 10 nm to as high as 0.1 µm (Harding and
Robinson 2010, Berg et al. 2010). Péclet number analyses were performed in two separate
alveolar models and found diffusion to dominate convective motion in all regions of the alveolar
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sac other than the inlet. Particles used in this work, 1 and 3 nm particles would have even higher
tendencies to diffuse based upon their significantly higher diffusion coefficients.
Also shown in the work performed by Harding and Robinson (2010) and Berg et al. (2010), the
effects of wall motion on the overall shape of the model is nearly unnoticed. There have been no
studies which effectively demonstrate the change in alveolar shape during inhalation. Harding
and Robinson (2010) did work combining some of the alveolar shape change articles into a
single chart. For a lung volume increase of 80%, the alveolar depth to mouth diameter (D/MD)
ratio changed by 0.6. Therefore, since the model walls move very little while expanding and
convective motion does not contribute to the motion of the particles, a static wall analysis
looking at purely diffusion can be assumed to accurately represent the deposition in the healthy
and emphysemic alveolar models for the particle sizes used in this study.

6.4.4 Effects of Sedimentation
If sedimentation were to be incorporated into the current results, it would have very little effect
for the 1 nm and 3 nm particles studied in this work. The settling velocities for a 1 nm particle
and 3 nm particles are 6.75E-09 and 2.04E-08 m/s, respectively. Therefore, each particle would
travel a total of 1.3 and 4 nm during a pause time of 0.2 seconds. The settling velocity only
increases to a value of 8.82E-07 m/s for a 0.01 µm particle, but for a 10 µm particle the settling
velocity increases to 3.06E-03 m/s. A particle of this size would move a greater distance by
gravity and could have an effect on particle deposition totals.

6.5 Conclusions
Two in vivo replica alveolar models, healthy and emphysematous, were created using lung
casting and 3D reconstruction techniques refined in our lab. The resulting geometry of the H and
E models were consistent with literature; in terms of general features and shapes of the alveoli.
The healthy and emphysemic models were simulated to determine deposition of 1 and 3 nm
particles by pure diffusion only, for the same localized model inlet particle concentration.
Deposition efficiencies showed qualitatively that the healthy model to be greater, which agrees
well with in vivo experimental data a stochastic model for emphysema presented in literature. A
local alveolar deposition method of measure was used to quantitatively compare simulation
results to experimental in vivo measurements and whole lung model results. Poor agreement was
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shown for local alveolar deposition fractions in most cases between our results and the
experimental measurements and whole lung models. However, our results agreed well with
simple straight tube diffusion solutions, which the whole lung models are based upon. It is
unknown the cause of the differences, additional work is needed experimentally and numerically
to better understand nanoparticle deposition in this region of the lungs.
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Appendix A – UDF Code
A.1 C code for UDF (FPM_Code.c)

/*
___DEFINITIONS_______________________________________________________*/
/*________________________________________________________________________*/
#include "fpm_user.h"/* Necessary for FPM to run, udf.h is called in
FPM program */
#include "fpm_bound_flux.h"
/*

___Define and assign constants */
#define MB_MAX_THREADS 50
#define INLET_ID 15
/*Inlet ID from BC panel*/
#define WALL_ID
14
/*Wall ID from BC panel*/

/*

___Define global variables */
FILE *solution, *residual, *fpm_wall_flux, *fpm_inlet_flux,
*fpm_outlet_flux;
real residuals[MAX_EQNS];
int old_iteration, new_iteration;
static void write_mass_balances(Domain *domain);
/*_________________________________________________________________________*/
/*
___FUNCTION HOOKS____________________________________________________*/
/*_________________________________________________________________________*/
/*
Hook this to the Define>User-Defined>Function Hooks>Initialization */
/*
DEFINE_INIT(udf_name, domain *d) */
/*
Creates solution, residual, wall, and inlet files with headings*/
DEFINE_INIT(init_patch, d)
{
old_iteration=0;
solution = fopen("solution.plt", "a");
fprintf(solution, "Run \tTime(s) \t\tTime Step Size(s) \tTotal
Iterations \t# of Iterations \t\tUDS-0 Equation \t\tUDS-1 Equation\n");
fclose(solution);
residual = fopen("residual.plt", "a");
fprintf(residual, "Iteration \tUDS-0 Equation \t\tUDS-1
Equation\n");
fclose(residual);
fpm_wall_flux = fopen("fpm_wall_flux.plt", "a");
fprintf(fpm_wall_flux, "Time \t\t\t\tUDS 0 - Wall\t\tUDS 1 Wall\n");
fclose(fpm_wall_flux);
fpm_inlet_flux = fopen("fpm_inlet_flux.plt", "a");
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fprintf(fpm_inlet_flux, "Time \t\t\t\tUDS 0 - Inlet\t\tUDS 1 Inlet\n");
fclose(fpm_inlet_flux);
}

/*
/*
/*

Hook this to the Define>User-Defined>Function Hooks>Adjust */
DEFINE_ADJUST(udf_name, domain *d) */
Extracts residuals and writes them to the file after each iteration */

DEFINE_ADJUST(res_list, domain)
{
int nw;
double scaled_res;
/*Message("\nResiduals for iteration %g",count2[nres-1]);*/
for(nw=0; nw<MAX_EQNS; ++nw)
{
/*Message("\n%i - %s equation:",nw,
DOMAIN_EQN_LABEL(domain,nw));*/
if(strlen(DOMAIN_EQN_LABEL(domain,nw))>0)
{
scaled_res=DOMAIN_RES(domain,nw)[nres1]/DOMAIN_RES_SCALE(domain,nw)[nres-1];
/*Message(" %e\n",scaled_res);*/
}
residuals[nw] = scaled_res;
}
residual = fopen("residual.plt", "a");
fprintf(residual, "%i \t\t%e \t\t%e\n", N_ITER, residuals[65],
residuals[66]);
fclose(residual);
}
/*
/*
/*

Hook this to the Define>User-Defined>Function Hooks>Execute At End */
DEFINE_EXECUTE_AT_END(udf_name) */
Calls flux routine and writes solution information to file */

DEFINE_EXECUTE_AT_END(run_each_dt)
{
Domain *dom = Get_Domain(1);
new_iteration = N_ITER - old_iteration;
write_mass_balances(dom);
solution = fopen("solution.plt", "a");
fprintf(solution, "%i \t%e \t%e \t\t%i \t\t\t%i \t\t\t\t%e
\t\t%e\n", N_TIME, CURRENT_TIME, CURRENT_TIMESTEP, N_ITER, new_iteration,
residuals[65], residuals[66]);
fclose(solution);
old_iteration = N_ITER;
}
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/*
Can be run by selection in Define>User-Defined>Execute On Demand... */
/*
DEFINE_ON_DEMAND(udf_name) */
/*
Performs same function as EXECUTE_AT_END for cases when time step is
interupted and routine is not called */
DEFINE_ON_DEMAND(on_demand)
{
Domain *dom = Get_Domain(1);
new_iteration = N_ITER - old_iteration;
write_mass_balances(dom);
solution = fopen("solution.plt", "a");
fprintf(solution, "%i \t%e \t%e \t\t%i \t\t\t%i \t\t\t\t%e
\t\t%e\n", N_TIME, CURRENT_TIME, CURRENT_TIMESTEP, N_ITER, new_iteration,
residuals[65], residuals[66]);
fclose(solution);

/*
/*
/*

old_iteration = N_ITER;
}
Hook this to Solve>Iterate by change time stepping to Adaptive*/
DEFINE_DELTAT(udf_name, domain *d) */
Controls time stepping parameters */

DEFINE_DELTAT(mydeltat, domain)
{
real time_step;
int run = N_TIME;
if (run <= 10)
time_step = 1e-5;
else
{
time_step = 1e-4;
}
return time_step;
}
/*_________________________________________________________________________*/
/*_________________________________________________________________________*/

/*
Routine which extracts flux data from FPM and writes to corresponding
file */
static void write_mass_balances (Domain *domain)
{
/*static REAL src[MAX_UDS_EQNS], sink[MAX_UDS_EQNS];
static REAL vsrc[MAX_SPE_EQNS], vsink[MAX_SPE_EQNS];*/
static REAL _flux[MAX_UDS_EQNS*MB_MAX_THREADS]/*,
_vflux[MAX_SPE_EQNS*MB_MAX_THREADS]*/;
REAL *flux/*, *vflux*/;
Thread *t, *t0;
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int i_thread[MB_MAX_THREADS];
int i;
int i_mb, n_mb;
i_mb = 0;
flux = _flux - MAX_UDS_EQNS;
/*vflux = _vflux - MAX_SPE_EQNS;*/
thread_loop_f (t, domain)
{
if (i_mb >= MB_MAX_THREADS)
{
Message("Max number of threads exceeded\n");
break;
}
t0 = THREAD_T0 (t);
if (!BOUNDARY_FACE_THREAD_P(t) || !THREAD_STORAGE (t,
SV_UDS_I(first_uds)) ||
THREAD_TYPE (t) == THREAD_F_AXIS || THREAD_TYPE (t)
== THREAD_F_SYMMETRIC || !FLUID_THREAD_P(t0))
continue;
i_thread[i_mb] = THREAD_ID(t);
flux += MAX_UDS_EQNS;
/*vflux += MAX_SPE_EQNS;*/
i_mb++;
}
n_mb = i_mb;
for (i_mb = 0, flux = _flux/*, vflux = _vflux*/;i_mb <
n_mb;i_mb++, flux += MAX_UDS_EQNS/*, vflux += MAX_SPE_EQNS*/)
{
/*FPM_Message ("%10d", i_thread[i_mb]);*/
if(i_thread[i_mb]==WALL_ID)
{
fpm_wall_flux = fopen("fpm_wall_flux.plt","a");
fprintf(fpm_wall_flux,"%e", CURRENT_TIME);
for (i = first_uds; i < last_uds; ++i)
{
fprintf(fpm_wall_flux,"\t\t%e",RIT_uds_flux[i_mb][i]);
}
fprintf(fpm_wall_flux,"\n");
fclose(fpm_wall_flux);
}
if(i_thread[i_mb]==INLET_ID)
{
fpm_inlet_flux =
fopen("fpm_inlet_flux.plt","a");
fprintf(fpm_inlet_flux,"%e", CURRENT_TIME);
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for (i = first_uds; i < last_uds; ++i)
{
fprintf(fpm_inlet_flux,"\t\t%e",RIT_uds_flux[i_mb][i]);
}
fprintf(fpm_inlet_flux,"\n");
fclose(fpm_inlet_flux);
}

/*for (i = 0; i < GAS_MAXSPECIES; i++)
{
FPM_Message ("|%14.6e", vflux[i]);
vbal[i] += vflux[i];
species_flux[i] = vflux[i]; //STORING SPECIES FLUXES SO THEY
ARE AVAILABLE OUTSIDE OF do_mass_balances
}
FPM_Message ("\n");*/
}
/*FPM_Message ("%10s", "Source:

");

for (i = first_uds; i < last_uds; ++i)
{
FPM_Message ("|%14.6e", src[i]);
}
for (i = 0; i < GAS_MAXSPECIES; i++)
{
if (gas_udm_map[i] < 0) continue;
{
FPM_Message ("|%14.6e", vsrc[i]);
}
}
FPM_Message ("\n");
FPM_Message ("%10s", "Sink:

");

for (i = first_uds; i < last_uds; ++i)
{
FPM_Message ("|%14.6e", sink[i]);
}
for (i = 0; i < GAS_MAXSPECIES; i++)
{
if (gas_udm_map[i] < 0) continue;
{
FPM_Message ("|%14.6e", vsink[i]);
}
}
FPM_Message ("\n");
FPM_Message ("%10s", "Balance:

");

for (i = first_uds; i < last_uds; ++i)
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{
FPM_Message ("|%14.6e", bal[i]);
}
for (i = 0; i < GAS_MAXSPECIES; i++)
{
if (gas_udm_map[i] < 0) continue;
{
FPM_Message ("|%14.6e", vbal[i]);
}
}
FPM_Message ("\n");
for (i = 0; i < n_fpm_modes; i++)
{
invalid_cells += FPM_MODE_INVALID_COUNT (fpm_modes[i]);
empty_cells += FPM_MODE_EMPTY_COUNT (fpm_modes[i]);
}
if (invalid_cells)
{
FPM_Message ("No. of cells with invalid mode parameters:\n
");
for (i = 0; i < n_fpm_modes; i++)
{
FPM_Message ("Mode %d: %d
FPM_MODE_INVALID_COUNT(fpm_modes[i]));
FPM_Message ("\n");
}
}

", i,

if (empty_cells)
{
FPM_Message ("No. of cells with empty mode(s):\n
for (i = 0; i < n_fpm_modes; i++)
{
FPM_Message ("Mode %d: %d
FPM_MODE_EMPTY_COUNT(fpm_modes[i]));
FPM_Message ("\n");
}
}*/
}

");

", i,

A.2 C code for header (fpm_bound_flux.h)
/*
Extracts necessary data and variables from inside FPM program and
allows for use in UDF code */
#define MB_MAX_THREADS2 50 /* Taken from definition just before
do_mass_balances */
extern REAL RIT_uds_flux[MAX_UDS_EQNS*MB_MAX_THREADS2][MAX_UDS_EQNS],
RIT_species_flux[MAX_SPE_EQNS*MB_MAX_THREADS2][MAX_SPE_EQNS];
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